B (2010-2018)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2018

+Studies in 2000-2009 List
*Studies in Pre-2000 List
>Information in Another Section

BACK PAIN + (See Also PAIN, SPASTICITY, SPINAL CHORD INJURY)
>BENIGN PROSTATIC HYPERTROPHY (See PROSTATIC HYPERTROPHY)
BILE/BILE DUCTS +
BIMODAL/PARADOXICAL EFFECTS (A High Dose And a Low Dose Give Very Different Effects)
BIPOLAR DISORDER*+
BLADDER/URINARY FUNCTIONS*+
>BLEPHAROSPASM (See BLEPHAROSPASM 2000-2009 and MEIGE’S SYNDROME in PRE-2000)
BLISTERS/BLISTERING
BLOOD-BRAIN BARRIER/BLOOD-SPINAL CORD BARRIER +
BLOOD/PLATELETS/PLASMA/SERUM*+
BLOOD PRESSURE/VASORELAXATION*+

BLOOD-RETINAL BARRIER
BLOOD-SPINAL CORD BARRIER (See Also BLOOD-BRAIN BARRIER/BLOOD-SPINAL CORD BARRIER)
>BONES (See OSTEOPOROSIS/BONES and CARTILAGE)
>BONE CEMENT IMPLANTATION SYNDROME (See HIP REPLACEMENT, 2000-2009 Section)
BONE MARROW
BOOKS (Open Section – No Date Restrictions)
BORDERLINE PERSONALITY DISORDER
BOWEL DISORDERS*+ (See Also GERD, COLITIS, IBS, CROHN’S DISEASE)
>BRAIN CELLS (See NEURONS)
>BRAIN–MENTAL EFFECTS (See COGNITIVE EFFECTS/IQ/MEMORY)
BRAIN*+
BRAIN TRAUMA*+ (See Also CHRONIC TRAUMATIC ENCEPHALOPATHY)
BREASTFEEDING/LACTATION/INFANT APPETITE*+
>BRUEGHEL’S SYNDROME (See MEIGE’S SYNDROME [Pre-2000 List])
BULIMIA +
BURNING MOUTH SYNDROME
BURN INJURIES +
BUSINESS OF CANNABIS/CANNABIS JOBS


BACK PAIN +
Investigational pharmacology for low back pain (full-2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3004649/?toolmcentrez
Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different
Etiopathogenesis (full–2012)  https://academic.oup.com/painmedicine/article/13/9/1121/1864240
Cannabinoids and muscular pain. Effectiveness of the local administration in rat (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22354705
When Weed Is The Cure: A Doctor’s Case for Medical Marijuana (interview–2015) http://www.npr.org/sections/health-shots/2015/07/14/422876973/when-weed-is-the-cure-a-doctors-casefor-medical-marijuana?utm_medium=RSS&utm_campaign=authorinterviews
Contribution of Endocannabinoid Gene Expression and Genotype on Low Back Pain
Susceptibility and Chronicity (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28481838


BILE/BILE DUCTS +
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5- HT1A receptor activation (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829220/
G1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion (link to PDF–2010) http/www.europeanreview.org/article/724
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted
from Cannabis sativa, on inflammation-induced hypermotility in mice (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417459/
Distribution of free and conjugated cannabinoids in human bile samples (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22980143
Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile
Acid Enzyme Genes Expression Via CREBH (full–2013)
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068845
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25179573
Gut microbiota and obesity: Role in aetiology and potential therapeutic target (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25194177
Bile salt recognition by human liver fatty acid binding protein (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25639618
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression (full–2015) http://ajpendo.physiology.org/content/308/7/E583.long
Fatty acid binding protein 5 (FABP5) regulates diet-induced obesity (DIO) via GIP secretion from enteroendocrine K-cells in response to fat ingestion (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25628425
Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury (full–2015) http://dmd.aspetjournals.org/content/43/11/1751.long
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040794/
Bile Acid Recognition by NAPE-PLD (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acschembio.6b00624
Distribution of Synthetic cannabinoids JWH-210, RCS-4 and ∆ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834143
top


BIMODAL/PARADOXICAL EFFECTS
Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain (full–2010)
http://www.oarsijournal.com/article/S1063-4584%2810%2900315-8/fulltext
Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms (full-2010) http://www.mdpi.com/1424-8247/3/7/2163/htm
Bimodal control of stimulated food intake by the endocannabinoid system (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20139974
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: antiinvasion activity at low concentration and apoptosis induction at high concentration. (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19916793
Cannabinoids and anxiety (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21309120
Cannabinoid mediated diuresis in mice (abst–2011)  http://www.fasebj.org/content/25/1_Supplement/617.6.abstract?sid=bfb1e75f-05db-4b4a-b24d-cabbb51eb934
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473327/
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently (full–2012)
http://ijnp.oxfordjournals.org/content/16/2/393.long
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full–2012) http://www.jneurosci.org/content/32/21/7109.long
Cannabinoids: A new hope for breast cancer therapy? (full-2012)  http://www.academia.edu/23263803/Cannabinoids_A_new_hope_for_breast_cancer_therapy
Review article: Endocannabinoids in neuroendopsychology: multiphasic control of
mitochondrial function (full–2012)  http://rstb.royalsocietypublishing.org/content/367/1607/3342.full?sid=dd42995f-c629-4f8c-86a0-5e962e352fda
Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697741/
Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1
receptor (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812000068
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor
activity (full–2013) http://ijnp.oxfordjournals.org/content/16/10/2273
Rapid Glucocorticoid-Induced Activation of TRP and CB1 Receptors Causes Biphasic
Modulation of Glutamate Release in Gastric-Related Hypothalamic Preautonomic
Neurons (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560102/
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene (abst–2013)  http://onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2011.00380.x/abstract
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional
Memory Formation via Functional Interactions with the Ventral Tegmental Area (full–2014) http://www.jneurosci.org/content/34/39/13096.long
Cannabinoid CB1 receptor signaling dichotomously modulates inhibitory and excitatory
synaptic transmission in rat inner retina (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25273281
Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic (full–2015) http://www.ccjm.org/index.php?id=107953&tx_ttnews[tt_news]=412809&cHash=0c1f8670f2fa499ee88aeff79ee2a47e
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect (full–2015) http://www.hindawi.com/journals/crigm/2015/405238/
Current Status and Future of Cannabis Research (full–2015)
http://cannabisclinicians.org/wp-content/uploads/2015/05/Russo-et-al-Current-status-and-future-ofcannabis-research-Clin-Researcher-2015.pdf
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26370914
Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26226145
CB1 receptors into the Prelimbic Cortex modulate food intake in rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0278584615000068
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease (full–2016) http://www.hindawi.com/journals/np/2016/8373020/
Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153327 
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/cns.12506/full
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00493/full
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice (full–2016) http://jpet.aspetjournals.org/content/early/2016/05/26/jpet.116.232132.long
Concentration, population, and context-dependent effects of AM251 in zebrafish (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26883874
Intra-VTA anandamide infusion produces dose-based biphasic effects on male rat sexual behavior expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302258
Endocannabinoid system in sexual motivational processes: is it a novel therapeutic horizon? (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816312385
Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human
osteosarcoma (full–2017) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=17089&path%5B%5D=54691
The current status of artisanal cannabis for the treatment of epilepsy in the United States
(full–2017)  https://www.projectcbd.org/sites/projectcbd/files/downloads/the_current_status_of_artisanal_cannabis_for_the_treatment_of_epilepsy_in_the_united_states.pdf
Recent legalization of cannabis use: effects on sleep, health, and workplace safety (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656354/
Neuroprotective properties of endocannabinoids N-arachidonoyl dopamine and Ndocosahexaenoyl dopamine examined in neuronal precursors derived from human
pluripotent stem cells (2 pages–2017)  https://link.springer.com/article/10.1134%2FS0006297917110141
Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating
p38 MAPK and p42/44 MAPK (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28601556
Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28127623
Effects of tetrahydrocannabinol on glucose uptake in the rat brain (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817300564
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30220-X/fulltext
Cannabis constituent synergy in a mouse neuropathic pain model (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28885457
The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further
evidence for transporter-mediated endocannabinoid release (abst–2017)  https://www.sciencedirect.com/science/article/pii/S002839081730549X?via%3Dihub
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress
(abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599212


BIPOLAR DISORDER*+
Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21658778
Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22818174
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24126189
Is there a role for palmitoylethanolamide in the treatment of depression? (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24630855
The association between cannabis use and mood disorders: A longitudinal study (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25451420
A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure  (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666428/
Endocannabinoids and Mental Disorders (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_8
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157060
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Lipids in psychiatric disorders and preventive medicine (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27033329
Brain circuitry associated with the development of substance use in bipolar disorder and
preliminary evidence for sexual dimorphism in adolescents. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123602/
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26903256 Cannabinoid hyperemesis syndrome and the onset of a manic episode (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27122104
The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27710762
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and
Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Cannabis Use and Hypomania in Young People: A Prospective Analysis (full–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29207008
Associations between substance use disorders and suicide or suicide attempts in people
with mental illness: A Danish nationwide, prospective, register-based study of patients
diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality
disorder (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28192643
Concurrent use of cannabis and alcohol: neuropsychiatric effects and consequences  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28440194
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and
bipolar disorder patients with cannabis use (full–2018)  http://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)32024-2/fulltext
Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder
versus schizophrenia, or other psychotic disorders (abst–2018) http://www.psy-journal.com/article/S0165-1781(17)31110-1/fulltext


BLADDER/URINARY FUNCTIONS*+
Functional role of cannabinoid receptors in urinary bladder (full-2010) http://www.indianjurol.com/article.asp?issn=0970- 1591;year=2010;volume=26;issue=1;spage=26;epage=35;aulast=Tyagi
Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20207474
Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19733001
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis (abst–2010) http/www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=314
Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction (full–2010) http/www.jurology.com/article/S0022-5347%2810%2904713-0/fulltext
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents (full–2011) http/www.molecularpain.com/content/pdf/1744-8069-7-31.pdf
top

Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3235339/
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011)  http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21310467
Cannabinoids: potential targets for bladder dysfunction (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21290238
Cannabinoid mediated diuresis in mice (abst-2011) http/www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/617.6?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT
Spinal Cord Fatty Acid Amide Hydrolase (FAAH) in Normal Micturition Control and Bladder Overactivity in Awake Rats (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/23219540
The afferent system and its role in lower urinary tract dysfunction (abst–2011)
http://www.ncbi.nlm.nih.gov/pubmed/21537194
Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/21930339
Cannabinoid Receptor Antagonist-Induced Striated Muscle Toxicity and Ethylmalonic Adipic Aciduria in Beagle Dogs (full–2012)  http://toxsci.oxfordjournals.org/content/129/2/268.full
Spinal Cord Fatty Acid Amide Hydrolase (FAAH) in Normal Micturition Control and
Bladder Overactivity in Awake Rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23219540
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22954177
Distribution and function of the endocannabinoid system in the rat and human bladder (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/23081739
Diuretic effects of cannabinoids (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3533417/
Bladder function in a cannabinoid receptor type 1 knock-out mouse (full–2013) http/onlinelibrary.wiley.com/doi/10.1111/bju.12350/full
Stable Binding of Alternative Protein-enriched Food Matrices with Concentrated
Cranberry Bioflavonoids for Functional Food Applications (full-2013)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769697/
Diuretic effects of cannabinoid agonists in mice (abst–2013) http/www.sciencedirect.com/science/article/pii/S0014299913007176
Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23908133
Future direction in pharmacotherapy for non-neurogenic male lower urinary tract
symptoms (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23711541
Effectiveness of vaginal adelmidrol for treating pelvic visceral discomforts and anxiety: a
prospective observational study (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24051946
Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24142157
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology (full-2014) http/www.neurology.org/content/82/17/1556.long
Current and future drugs for treatment of MS-associated bladder dysfunction (full–2014) http/www.sciencedirect.com/science/article/pii/S187706571401728X
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25467189
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25374388
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24746881
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
Cannabinoids and the endocannabinoid system in lower urinary tract function and
dysfunction (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/24285567
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446380/
top

Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25575795
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015)
http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25788026
URB937, a peripherally-restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano afferent nerve fibers in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26189783
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26197538
Cannabinoid receptor expression in the bladder is altered in detrusor overactivity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26224382
The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26243021
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_14
New therapeutic strategies for the treatment of male lower urinary tract symptoms (full–2016) https://www.dovepress.com/new-therapeutic-strategies-for-the-treatment-of-male-lower-urinary-tra-peerreviewed-article-RRU
Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker
Rat: Role of Cannabinoid Receptors (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902197/
Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice (full–2016) http://jpet.aspetjournals.org/content/early/2016/05/26/jpet.116.232132.long
Unmasking roles of the peripheral endocannabinoid system associated with bladder overactivity (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bju.13336/full
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26942594
Anandamide transporter-mediated regulation of the micturition reflex in urethaneanesthetized rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27256398
The endocannabinoid system – a target for the treatment of LUTS? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27377161
Potential Future Pharmacological Treatment of Bladder Dysfunction (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26990140
Role of Cannabinoid Receptor Type 1 in Tibial and Pudendal Neuromodulation of Bladder Overactivity in Cats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27927655
Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2
receptor agonists on detrusor overactivity associated with bladder outlet obstruction in
rats (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747270/
Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with
multiple sclerosis: a systematic review and meta-analysis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28058780
Metabolic Syndrome Induced Bladder Cannabinoid Receptor Changes in the Fructose Fed
Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28386998
Impact of Regular Cannabis Use on Biomarkers of Lower Urinary Tract Function (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28827195
THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a
pilot prospective study (abst–2017) https://link.springer.com/article/10.1007%2Fs10072-017-3148-6


BLEPHAROSPASM
Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/29339959


BLISTERS/BLISTERING
Mustard vesicants alter expression of the endocannabinoid system in mouse skin (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X16300898


BLOOD-BRAIN BARRIER/BLOOD-SPINAL CORD BARRIER +
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) (full–2010) http://ijnp.oxfordjournals.org/content/13/7/905.long
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260554/
Anandamide inhibits Theiler’s virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors (full-2011) http/www.jneuroinflammation.com/content/pdf/1742-2094-8-102.pdf
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model (full–2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0018490
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions (full-2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3325902/
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3312.long
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff- 857201f5e069
Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22678129
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/22903455
Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption
in focal cerebral ischemia in rats (abst–2012)  https://www.karger.com/Article/Abstract/338755
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic
injury by activating peroxisome proliferator-activated receptor α. (abst–2012)
http://www.sciencedirect.com/science/article/pii/S0028390812001062
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636589/
Multiple sclerosis and the blood-central nervous system barrier (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full-2013) http/www.sciencedirect.com/science/article/pii/S0969996113001939
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier (full-2013) http/ajp.amjpathol.org/article/S0002-9440%2813%2900557-9/fulltext
Control of spasticity in a multiple sclerosis model using central nervous system-excluded
CB1 cannabinoid receptor agonists (full–2013)  http://www.fasebj.org/content/28/1/117.long
Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23831388
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier (full-2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
top

Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full-2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular
inflammatory responses to traumatic brain injury (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248435/
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24819918
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25166905
Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by
regulating membrane permeability and the epithelial-mesenchymal transition (full–2014) http://www.spandidos-publications.com/ijo/44/1/187;jsessionid=D37A8D6D01845D28427059EB11FE132D?text=fulltext
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24874648
Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24929655
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington’s disease brain (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24978314
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/25015040
Cannabinoids, eating behaviour, and energy homeostasis (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24375977
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation (full-2015) http://www.jneuroinflammation.com/content/pdf/s12974-015-0307-7.pdf
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13106/full
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium (full-2015) http://tinyurl.com/obffgfh
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full-2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26376816
The brain in bone and fuel metabolism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26545334
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygen glucose deprivation via PPARγ and 5-HT1A (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497782
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (full–2016) https://peerj.com/articles/2081/
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism (full–2016) http://www.jbc.org/content/early/2016/07/29/jbc.M116.746594.long
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015205a.html
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target (abst–2016) http://www.eurekaselect.com/141330/article
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00516
Endocannabinoids: A Promising Impact for Traumatic Brain Injury (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues
for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid
system protects against colitis and ameliorates remote organ lesions in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740744/
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28637354
Targeting fatty-acid amide hydrolase with prodrugs for CNS-selective therapy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28756656
Chapter Eleven – Is the Cannabinoid CB2 Receptor a Major Regulator of the  Neuro-inflammatory Axis of the Neurovascular Unit in Humans? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1054358917300376?via%3Dihub
Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and
Associated Diseases (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28913816


BLOOD/PLATELETS/PLASMA/SERUM*+
Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma (full-2010) http/www.jlr.org/content/51/6/1416.full.pdf+html
The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle (abst-2010) http/www.ncbi.nlm.nih.gov/pubmed/19200965
Pain related behaviors and neurochemical alterations in mice expressing sickle
hemoglobin: modulation by cannabinoids (full-2010)  http://bloodjournal.hematologylibrary.org/content/116/3/456.long
Effect of anandamide in Plasmodium Berghei-infected mice (full–2010)  http://www.karger.com/Article/Pdf/320559
New Era Dawns on Sickle Cell Pain (full-2010)  http://bloodjournal.hematologylibrary.org/cgi/reprint/116/3/311
Anandamide extends platelets survival through CB(1)-dependent Akt signaling (abst-2010) http/www.ncbi.nlm.nih.gov/pubmed/19936621
Probable Interaction Between Warfarin and Marijuana Smoking (abst-2010)
http://www.unboundmedicine.com/medline/ebm/record/19531696/abstract/Probable_Interaction_Between_Warfarin_and_Marijuana_Smoking__July/August__
Effect of Cannabis sativa on Hematological Indices in Rats and Men (full-2011) http/docsdrive.com/pdfs/ansinet/pjn/2011/313-316.pdf
Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte
chemotaxis (full–2011)
https://www.jstage.jst.go.jp/article/bpb/34/7/34_7_1090/_pdf

Immune thrombocytopenia in children and adults: what’s the same, what’s different?
(full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232253/
Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids? (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21664223
The endocannabinoid system and its role in schizophrenia: a systematic review of the literature (full-2012) http/www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000600005&lng=en&nrm=iso&tlng=en
Off-Target Cannabinoid Effects Mediated by GPR55 (full–2012)  https://www.karger.com/Article/FullText/336872
Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T
lymphocytes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22823387
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft
Rejection, the Mixed Lymphocyte Reaction (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864984/
Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder (full-2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062741
Differential Expression of Intracellular and Extracellular CB(2) Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3587044/
A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function (full-2013) http/jpet.aspetjournals.org/content/346/1/54.long
The Effect of Mifepristone (RU486) on the Endocannabinoid System in Human Plasma
and First Trimester Trophoblast of Women undergoing Termination of Pregnancy (full–2013) http://press.endocrine.org/doi/full/10.1210/jc.2013-2922
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks (abst-2013) http/www.psyneuen-journal.com/article/S0306-4530%2813%2900292-8/abstract
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study (full–2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085073
Influence of serum and albumin on the in vitro anandamide cytotoxicity toward C6
glioma cells assessed by the MTT cell viability assay: implications for the methodology
of the MTT tests (full–2013) http://www.termedia.pl/Original-article-Influence-of-serum-and-albumin-on-the-in-vitro-anandamide-cytotoxicity-toward-C6-gliomacells-assessed-by-the-MTT-cell-viability-assay-implications-for-the-methodology-of-the-MTT-test,20,20493,1,1.html
The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in
cytokine expression in the rat frontal cortex and plasma: differential mechanisms of
action (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687661/
Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23585028
top

Detection of the endocannabinoid metabolome in human plasma and breast milk (abst-2013) http/www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/45.8?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23702422
Mechanism of platelet activation induced by endocannabinoids in blood and plasma (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23789792
Plasma Anandamide and Related N-acylethanolamide Levels are not Elevated in
Pregnancies Complicated by Hyperemesis Gravidarum (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24117326
Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects (full-2014) http/onlinelibrary.wiley.com/doi/10.1002/oby.20728/full
Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0108282
Association of polymorphisms in the endocannabinoid system genes with myocardial infarction and plasma cholesterol levels (full-2014) http://biomed.papers.upol.cz/getrevsrc.php?identification=public&mag=bio&raid=825&type=fin&ver=3
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614031/
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25344934
GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte
compartment (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235638/
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in
lymphocyte subsets by IFN-β: a longitudinal study in multiple sclerosis patients (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full
Critical issues in the analysis of endocannabinoids and related compounds in plasma: artifactual isomerization and ex-vivo enzymatic generation of 2-monoacylglycerols (full-2014) http/www.jlr.org/content/early/2014/03/07/jlr.D043794.long
Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s) (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24361246
Effect of 2-arachidonoylglycerol on myosin light chain phosphorylation and platelet activation: The role of phosphatidylinositol 3 kinase/AKT pathway (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/25068972 
EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM (abst–2014)  https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751#sthash.pbnOqzNG.dpuf
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Expression Analysis of CB2-GFP BAC Transgenic Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138986
Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study (full–2015) http://www.biomedcentral.com/1756-0500/8/504
Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling (full–2015) https://peerj.com/articles/1056/
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770330/
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans (full–2015) http://jn.nutrition.org/content/145/9/2169.long
Components of the endocannabinoid and dopamine systems are dysregulated in
Huntington’s disease: analysis of publicly available microarray datasets (full-2015)
http://onlinelibrary.wiley.com/doi/10.1002/prp2.104/full
Downstream effects of endocannabinoid on blood cells: implications for health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Regulation of cAMP Intracellular Levels in Human Platelets Stimulated by 2- Arachidonoylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26460717
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0021915015301933
Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2 (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=11367&path%5B%5D=35984 Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (full–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30715-6/fulltext
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015205a.html
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens (full–2016) http://www.tandfonline.com/doi/full/10.4081/ijas.2015.3473
Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for Δ9-
Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (full–2016)  http://www.jbc.org/content/290/14/8711.full
Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep
Apnea (full–2016) http://www.hindawi.com/journals/bmri/2016/9782031/
Effects of activation of endocannabinoid system on myocardial metabolism. (click “ICI” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333924
Cannabinoids and haemostasis. (click “ICI” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27383573
Pre-hospital identification and post-recovery challenges of intoxication with synthetic
cannabinoid containing legal high products such as ‘Exodus Damnation’ (abst–2016) http://journals.sagepub.com/doi/full/10.1177/0036933016659177
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26761126
Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616300045
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer’s Disease and Mild Cognitive Impairment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825096
Anandamide and its metabolites: what are their roles in the kidney? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27100705
Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27151562
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27591408
Repeated Thrombosis After Synthetic Cannabinoid Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27595371
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816309021
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst–2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Peripheral Blood Mononuclear Cells Infiltration Downregulates Decidual FAAH Activity in an LPS-Induced Embryo Resorption Model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27731508
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27989579
Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28017680
Endocannabinoids concentrations in plasma associated with feed efficiency and carcass composition of beef steers (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28046144
Plasma endocannabinoid behaviour in total knee and hip arthroplasty (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28078867
LACTIC ACIDOSIS: A RARE MANIFESTATION OF SYNTHETIC MARIJUANA INTOXICATION (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27159480
Serum levels of endocannabinoids are independently associated with nonalcoholic fatty
liver disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863097
Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal  Cannabinoids (full–2017)  http://journal.frontiersin.org/article/10.3389/fnmol.2017.00014/full
Endocannabinoid tone is higher in healthy lean South Asian than white Caucasian men
(full–2017) https://www.nature.com/articles/s41598-017-07980-5
Anti-inflammatory ω-3 endocannabinoid epoxides (full–2017)  http://www.pnas.org/content/114/30/E6034.long
N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via
Nonhematopoietic TRPV1 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544930/
Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta adrenergic
stimulation (full–2017) http://www.exphem.org/article/S0301-472X(17)30813-5/fulltext
Cannabinoid Receptor 1 Gene by Cannabis Use Interaction on CB1 Receptor Density
(full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628563/
Endocannabinoid concentrations in plasma during the finishing period are associated with feed efficiency and carcass composition of beef cattle (full–2017)  https://academic.oup.com/jas/article/95/10/4568/4772022
First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid  (full–2017) https://www.dovepress.com/first-evidence-of-the-conversion-of-paracetamol-to-am404-in-human-cere-peer-reviewed-fulltext-articleJPR
The correlation of anandamide with gonadotrophin and sex steroid hormones during the
menstrual cycle (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749362/
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28108228
Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo (abst–2017) http://pubs.rsc.org/en/Content/ArticleLanding/2017/PP/C6PP00337K#!divAbstract
Alterations of the hematologic cells in synthetic cannabinoid users (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28169460
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia:
Evidence for defective immunomodulatory mechanisms (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0022395616307373
Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and
Differentiation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28364261
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis (abst–2017) https://www.karger.com/Article/Abstract/462974
A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem
Cells to Mature B Lymphocytes (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28413023
The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a
translational study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456476
Activation of CaMKKβ/AMPKα pathway by 2-AG in human platelets (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28661046
Circulating Endocannabinoids: From Whence Do They Come and Where are They
Going? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653665
Levels of oxylipins, endocannabinoids and related lipids in plasma before and after low level exposure to acrolein in healthy individuals and individuals with chemical
intolerance (abst–2017) http://www.plefa.com/article/S0952-3278(16)30153-3/fulltext
Association Between Plasma N-Acylethanolamides and High Hemoglobin Concentration
in Southern Peruvian Highlanders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28665150
Running Out of Options: Rhabdomyolysis Associated with Cannabis Hyperemesis
Syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28664257
Cannabinoids in the Cardiovascular System (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1054358917300431?via%3Dihub
Human serum albumin: A modulator of cannabinoid drugs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28976704
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in
those with pancreatic ductal adenocarcinoma (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28631495
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly
selective fatty acid amide hydrolase inhibitor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29017758
System-specific activity in response to Δ9 -tetrahydrocannabinol: A functional magnetic
resonance imaging study in awake male rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29057576
Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-
Arachidonoylglycerol in Humans (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29110806
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in
mice and its effects are potentiated by a ketogenic diet (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29171003
Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in
normal and high-fat fed male C57BL/6J mice (abst–2017)
https://www.sciencedirect.com/science/article/pii/S0041008X17304295?via%3Dihub
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29178411
Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits
markers of endotoxin exposure in healthy premenopausal women: a randomised
controlled trial (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29179781
A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in
Human Blood and Tonsil Immune System Cells (abst–2018)  http://pubs.acs.org/doi/10.1021/acs.bioconjchem.7b00680
Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29351454
HIV-infected cannabis users have lower circulating CD16+ monocytes and IFN-γ-inducible protein 10 levels compared with nonusing HIV patients (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29194121
Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids of female C57BL/6 mice (abst–2018) https://www.sciencedirect.com/science/article/pii/S1388198117302044?via%


BLOOD-PRESSURE/VASORELAXATION*+
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003779/
N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931560/
The cardiac and haemostatic effects of dietary hempseed (full-2010)
http://www.nutritionandmetabolism.com/content/pdf/1743-7075-7-32.pdf
Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962826/?tool=pubmed
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada) (full–2010) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors (abst–2010)
http://www.sciencedirect.com/science/article/pii/S1043661810001192
Cannabinoid CB1 receptor expression in relation to visceral adipose depots,
endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G
variant in humans (abst–2010) http://www.metabolismjournal.com/article/S0026-0495(09)00408-9/abstract
Cannabinoid and GABA modulation of sympathetic nerve activity and blood pressure in the dorsal periaqueductal gray of the rat (full-2011) http://ajpregu.physiology.org/content/301/6/R1765.full
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413845/
Increased Blood Pressure Following Abrupt Cessation of Daily Cannabis Use (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045206/
Endocannabinoid modulation of sympathetic and cardiovascular responses to acute stress in the periaqueductal gray of the rat (full–2011)  http://ajpregu.physiology.org/content/300/3/R771
Endocannabinoid system in cardiovascular disorders – new pharmacotherapeutic
opportunities (full–2011) http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha
Low-volume binary drug therapy for the treatment of hypovolemia (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21330941
top

Cannabinoids and sepsis (abst–2011)  http://www.trendsanaesthesiacriticalcare.com/article/S2210-8440%2811%2900049-9/fulltext
Endocannabinoids and the cardiovascular response to stress (abst-2011)
http://www.ncbi.nlm.nih.gov/pubmed/21708837
Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB1 receptors (full-2012) http://ajpregu.physiology.org/content/302/7/R876
Tolerance to Effects of High-Dose Oral {Delta}9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584989/
Serum contents of endocannabinoids are correlated with blood pressure in depressed women (full-2012) http://www.lipidworld.com/content/pdf/1476-511X-11-32.pdf
Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912002671
Angiotensin II induces vascular endocannabinoid release, which attenuates its
vasoconstrictor effect via CB1 cannabinoid receptors (full–2012)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438986/
Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22285599
Circulating anandamide and blood pressure in patients with obstructive sleep apnea (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23032139
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22627170
Cannabinoid receptor activation in the nucleus tractus solitaries produces baroreflex-like responses in the rat (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614708/
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537620/
Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24020800
Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24367128
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies (full–2013) http://www.karger.com/Article/FullText/350094
Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from
young obese zucker rats (full–2013)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063449
Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23340220
Mechanism of Central Atypical Cannabinoid Receptor GPR18-Mediated Hypotension in Conscious Rats (abst-2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/654.15?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Preventive and treatment effects of a hemp seed (Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24292743
Impaired hypotensive responses induced by intrathecally injected drugs in fructose-fed rats (abst–2013) https://www.ncbi.nlm.nih.gov/pubmed/23499700
Cardiorespiratory control as a function of wake-sleep behavior and diet in mice lacking
CB1 cannabinoid receptors (abst–2013)  http://www.fasebj.org/content/27/1_Supplement/926.1.short
Functional relevance of the cannabinoid receptor 2 – heme oxygenase pathway: A novel
target for the attenuation of portal hypertension (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/24007798
The Novel Endocannabinoid Receptor GPR18 is Expressed in the Rostral Ventrolateral Medulla and Exerts Tonic Restraining Influence on Blood Pressure (full-2014) http://jpet.aspetjournals.org/content/early/2014/01/15/jpet.113.209213.long
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries (full-2014) http://download.springer.com/static/pdf/387/art%253A10.1007%252Fs00210-014-0961-9.pdf?auth66=1396559334_2a7771f3b0767a5092c7c4a570374992&ext=.pdf
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
A new face of endocannabinoids in pharmacotherapy. Part I: Protective role of endocannabinoids in hypertension and myocardial infarction (full-2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/171_04_14_article.pdf
top

A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full-2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/183_04_14_article.pdf
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors (full-2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100536
A novel hemp seed meal protein hydrolysate reduces oxidative stress factors in spontaneously hypertensive rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276990/
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995979/
Neuronal Nitric Oxide Synthase Dependent Elevation in Adiponectin in the Rostral Ventrolateral Medulla Underlies GPR18-mediated Hypotension in Conscious Rats (full-2014) http://jpet.aspetjournals.org/content/early/2014/08/06/jpet.114.216036.long
Cannabidiol improves vasorelaxation in Zucker Diabetic fatty rats through
cyclooxygenase activation (full–2014) http://jpet.aspetjournals.org/content/351/2/457.long
Cyclooxygenase metabolism mediates vasorelaxation to 2-Arachidonoylglycerol (2-AG)
in human mesenteric arteries (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992009/
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature (full–2014) http://www.sciencedirect.com/science/article/pii/S001429991400274X?via%3Dihub
Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24561046
Role of endocannabinoid 2-arachidonoylglycerol in the physiology and pathophysiology of the cardiovascular system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934539
The hypotensive effect of intrathecally injected (m)VD-hemopressin(α) in urethane anesthetized rats (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24681436
The Endocannabinoid Anandamide Mediates Hypoxic Pulmonary Vasoconstriction And Pulmonary Hypertension (abst–2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A5558
Structural and functional characterization of hemp seed (Cannabis sativa L.) proteinderived antioxidant and antihypertensive peptides (abst–2014) http://www.sciencedirect.com/science/article/pii/S1756464613002594
Terpenes and Lipids of the Endocannabinoid and Transient Receptor Potential-channel
Biosignaling Systems (abst–2014) http://pubs.acs.org/doi/abs/10.1021/cn5000875
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315049/
Effects of high-fructose diets on central appetite signaling and cognitive function (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/
Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus (full–2015)  http://www.jpp.krakow.pl/journal/archive/06_15/pdf/343_06_15_article.pdf
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation (full–2015) http://cardiovascres.oxfordjournals.org/content/early/2015/06/30/cvr.cvv179.long Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492759/
What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension? (full–2015) http://www.cmjournal.org/content/10/1/36
METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523241/
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (full-2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet induced obesity (full–2015) http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.13056
Central GPR109A Activation Mediates Glutamate-Dependent Pressor Response in
Conscious Rats (full–2015) http://jpet.aspetjournals.org/content/356/2/456.abstract?sid=97527854-e2fb-4d74-ad96-6ab0744dc240
Alterations in the Medullary Endocannabinoid System contribute to age related impairment of Baroreflex Sensitivity (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25636077
The GPR55 agonist lysophosphatidylinositol mediates vasorelaxation of the rat
mesenteric resistance artery and induces calcium release in rat mesenteric artery
endothelial cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459022/
Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-
arachidonoylglycerol (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950792/
Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes  (link to PDF–2015) http://www.ncbi.nlm.nih.gov/pubmed/25711828
Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signalinginduced vasoconstriction and hypertension (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0303720715000167
Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25672659
Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515002155
Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26173564
Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26297305
Endocannabinoids and the Cardiovascular System in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408169
Cannabinoid 2 receptoractivation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26410875
Cannabinoids-Induced Vasodilation in Rat Mesenteric Artery: Possible Mechanisms of Action (abst–2015) http://www.fasebj.org/content/29/1_Supplement/948.6.abstract?sid=edf921ac-0690-4aa6-ac81- 0546314dd384
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data (full – 2016) http://www.amjmed.com/article/S0002-9343(15)01024-4/fulltext
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression. (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899471/
Vascular Dysfunction in a Transgenic Model of Alzheimer’s Disease: Effects of CB1R and CB2R Cannabinoid Agonists (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00422/full
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries (full–2016)  http://www.sciencedirect.com/science/article/pii/S104366181630113X
Components of the cannabinoid system in the dorsal periaqueductal gray are related to resting heart rate (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982395/
CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00210-016-1302-y
Endocannabinoids in Cerebrovascular Regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP dependent vasorelaxant (full–2016)  http://www.sciencedirect.com/science/article/pii/S0014299916307439?via%3Dihub
Effects of activation of endocannabinoid system on myocardial metabolism (click “ICI” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333924
Pre-hospital identification and post-recovery challenges of intoxication with synthetic cannabinoid containing legal high products such as ‘Exodus Damnation’ (full–2016) http://journals.sagepub.com/doi/full/10.1177/0036933016659177
Age-specific influences of chronic administration of the fatty acid amide hydrolase
inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt
hypertensive rats (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1734114015003412
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26761126
Adverse effects after the use of JWH-210 – a case series from the EU Spice II plus project (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768345
Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320516301643
Anandamide and its metabolites: what are their roles in the kidney? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27100705
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X1630076X
Marijuana Use and Its Effects in Pregnancy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27263998
Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27436749
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529509
The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27676325
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools (abst–2016) http://www.eurekaselect.com/146167/article Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861247
Bilateral renal cortical necrosis associated with smoking synthetic cannabinoids (full–2017) https://www.wjgnet.com/2307-8960/full/v5/i6/234.htm
In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in
Mesenteric Arteries of Zucker Diabetic Fatty Rats (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436470/
Mechanisms of l-alpha-lysophosphatidylinositol-induced relaxation in human pulmonary arteries (full–2017)  http://www.sciencedirect.com/science/article/pii/S0024320517305982?via%3Dihub
Redox system and phospholipid metabolism in the kidney of hypertensive rats after
FAAH inhibitor URB597 administration (full–2017)  http://www.sciencedirect.com/science/article/pii/S2213231717308303
Profound hypotension and bradycardia in the setting of synthetic cannabinoid
intoxication – A case series (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28238395
Activation of CB1 receptors by 2-arachidonoylglycerol attenuates vasoconstriction
induced by U46619 and angiotensin II in human and rat pulmonary arteries (abst–2017) http://ajpregu.physiology.org/content/early/2017/03/27/ajpregu.00324.2016
Metabolic Syndrome Induced Bladder Cannabinoid Receptor Changes in the FructoseFed
Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28386998
Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic
Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28397128
Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects
on cardiac performance in normotensive and hypertensive rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28437860
The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive
and DOCA-salt hypertensive rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28633967
Stimulation of diuresis and natriuresis by renomedullary infusion of a dual inhibitor of
fatty acid amide hydrolase and monoacylglycerol lipase (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28768662
Cannabinoids in the Cardiovascular System (abst–2017)
http://www.sciencedirect.com/science/article/pii/S1054358917300431?via%3Dihub
Synthetic cannabinoids found in “spice” products alter body temperature and
cardiovascular parameters in conscious male rats (abst–2017)
http://www.drugandalcoholdependence.com/article/S0376-8716(17)30415-5/fulltext
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30220-X/fulltext
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis (abst–2017) https://www.karger.com/Article/Abstract/462974
Control of myogenic tone and agonist induced contraction of intramural coronary  resistance arterioles by cannabinoid type 1 receptors and endocannabinoids (abst–2017) http://www.sciencedirect.com/science/article/pii/S1098882317300047
Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid
Receptor Agonists: From Horizon Scanning to Notification (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29038156
Cannabinoids Regulate the Diameter of Pericyte-Containing Retinal Capillaries in Rats  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29059679
ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through
cannabinoid receptors, BKCa channels, and nitric oxide dependent mechanisms (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29128791
The endocannabinoid system in cardiovascular function: novel insights and clinical
implications (abst–2017) https://link.springer.com/article/10.1007%2Fs10286-017-0488-5
Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits
markers of endotoxin exposure in healthy premenopausal women: a randomised
controlled trial (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29179781
New ACE-Inhibitory Peptides from Hemp Seed (Cannabis sativa L.) Proteins (abst–2017) http://pubs.acs.org/doi/10.1021/acs.jafc.7b04522


BLOOD-RETINAL BARRIER
Anandamide rescues retinal barrier properties in Müller glia through nitric oxide  regulation (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25453774


BLOOD-SPINAL CORD BARRIER*+
The molecular mechanism and effect of cannabinoid-2 receptor agonist on the blood spinal cord barrier permeability induced by ischemia-reperfusion injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26835555
Remote Ischemia Preconditioning Attenuates Blood-Spinal Cord Barrier Breakdown in
Rats Undergoing Spinal Cord Ischemia Reperfusion Injury: Associated with Activation
and Upregulation of CB1 and CB2 Receptors (full–2017)  https://www.karger.com/Article/FullText/484460


BONE MARROW
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis (full–2010) http://onlinelibrary.wiley.com/doi/10.1002/art.27642/full
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3109635/?toolubmed
Peripheral cannabinoid type 2 receptor regulates osteoclast formation, MDA-MB-231
breast cancer cell migration and bone marrow/tumour cell interaction via PI3 kinase / AKT and P38 pathways (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2901828-4/abstract
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early
Atherosclerosis in LDL Receptor Deficient Mice (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109635/?tool=pubmed
Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/22074629
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell
immunosuppressive properties (full–2013)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080022
Activation of cannabinoid receptor 2 enhances osteogenic differentiation of bone marrow derived mesenchymal stem cells (full-2015) http://www.hindawi.com/journals/bmri/2015/874982/
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the
Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo (full–2015) http://www.jimmunol.org/content/194/11/5211.long
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712127/
Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem
Cells Triggered by Chronic Liver Injury (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27028843
Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta adrenergic
stimulation (full–2017) http://www.exphem.org/article/S0301-472X(17)30813-5/fulltext
Restoration of osteogenic differentiation by overexpression of cannabinoid receptor 2 in
bone marrow mesenchymal stem cells isolated from osteoporotic patients (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729701/
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes (abst–2017) http://diabetes.diabetesjournals.org/content/early/2017/01/11/db16-1199.long
A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem
Cells to Mature B Lymphocytes (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28413023
Cannabinoid Receptor 2 Modulates Neutrophil Recruitment in a Murine Model of
Endotoxemia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28852269
Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis and Cardiac Function
After Myocardial Infarction (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29167227


BOOKS+
Aging & Medical Marijuana (booklet–undated)  http://www.safeaccessnow.org/aging_booklet
Nabilone for Non-chemotherapy Associated Nausea and Weight Loss due to Medical Conditions: A Review of the Clinical Effectiveness and Guidelines [Internet] (full–2014) http://www.ncbi.nlm.nih.gov/books/NBK253668/toc/?report=reader
On Being Stoned: A Psychological Study of Marijuana Intoxication (book-1971) http://www.druglibrary.org/special/tart/tartcont.htm
Ganja in Jamaica (book-download–1975)  http://cifas.us/pdf/Comitas%20Pdf%20Files/Long%20Manuscripts/1975a%20Ganja%20in%20Jamaica.pdf
Marijuana – The First Twelve Thousand Years (book–1980)  http://www.druglibrary.org/Schaffer/hemp/history/first12000/abel.htm
Hemp and Health (book-1999) http://www.rexresearch.com/hhusb/hmphlth.htm#hhl2s
The Science of Marijuana (book–2000)  http://www.green215.com/sites/all/files/education_articles/Science%20Cannabis.pdf
The Emperor Wears No Clothes (a “must read”!) (book-2007)  http://jackherer.com/emperor-3/
Cannabis; extracting the medicine (book–2007)  http://mcforadhd.free.fr/Hazekamp%20EXTRACTING%20THE%20MEDICINE.pdf
Nabilone for Non-chemotherapy Associated Nausea and Weight Loss due to Medical
Conditions: A Review of the Clinical Effectiveness and Guidelines [Internet] (full–2014) http://www.ncbi.nlm.nih.gov/books/NBK253668/toc/?report=reader
David Casarett’s Stoned: A Doctor’s Case for Medical Marijuana (full–book review-2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938260/
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (book-link to PDF–2017)  https://www.ncbi.nlm.nih.gov/books/NBK423845/


>BORDERLINE PERSONALITY DISORDER
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/437/?pagenum=2
Borderline personality traits and substance use: genetic factors underlie the association with smoking and ever use of cannabis, but not with high alcohol consumption (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744119/
Fatty acid ethanolamide levels are altered in borderline personality and complex
post traumatic stress disorders (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24253425
Identity disturbance and substance-dependence in patients with borderline personality disorder (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905504/
Cannabis use and suicidal ideations in high-school students (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
top

Genetic variation in personality traits explains genetic overlap between borderline personality features and substance use disorders (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25041562
A New Perspective on the Pathophysiology of Borderline Personality Disorder: A Model of the Role of Oxytocin (full–2015) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2015.15020216
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27149691
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Associations between substance use disorders and suicide or suicide attempts in people
with mental illness: A Danish nationwide, prospective, register-based study of patients
diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality
disorder (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28192643
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and
Related Conditions-III: Gender-specific profiles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28755613


BOWEL DISORDERS*+
Achalasia, status post myotomy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/597/?pagenum=2
Rectal spasms (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/791/
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn’s Disease (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829088/?tool=pmcentrez
The endocannabinoid system links gut microbiota to adipogenesis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925525/
Endocannabinoid control of gastric sensorimotor function in man (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2010.04259.x/full
Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability (full-2010) http://jpet.aspetjournals.org/content/335/1/92.full
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice. (full – 2010) http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00132/full
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases (full-2010) http://www.freepatentsonline.com/EP2044935A1.html
Cannabinoids and the gut: New developments and emerging concepts (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20117132
Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2009.01419.x/pdf
Gut feelings about the endocannabinoid system (full-2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?toolubmed
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
ENDOGENOUS CANNABINOID SYSTEM REGULATES INTESTINAL BARRIER FUNCTION IN VIVO THROUGH CANNABINOID TYPE 1 RECEPTOR ACTIVATION (full–2011) http/ajpgi.physiology.org/content/early/2011/11/28/ajpgi.00158.2011.full-text.pdf+html
Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117918/
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21876860
The endogenous cannabinoid system in the gut of patients with inflammatory bowel
disease (full–2011) http://www.nature.com/mi/journal/v4/n5/full/mi201118a.html
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents (full–2011) https/www.google.com/patents/US7884133?dqatent+7884133&hl=en&sa=X&ei=Ujb0U_6EEIW5ogSl84LYDg&ved=0CB4Q6AEwAA
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423254/
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in
health and disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624216/
Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model (full–2011)  http://jpet.aspetjournals.org/content/early/2011/06/14/jpet.111.182717.long
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full–2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01742.x/full
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation (full–2011) http/www.fasebj.org/content/25/8/2711.long
top
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21726418
The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus (abst–2011) http/www.unboundmedicine.com/medline/ebm/record/21975813/abstract/The_effects_of_cannabidiolic_acid_and_cannabidiol_on_contractility_of_the_gastrointestinal_tract_of_Suncus_murinus_
Effects of Cannabinoid Agonists on Sheep Sphincter of Oddi in vitro (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21921665
Inhibition of cannabinoid metabolic enzymes reduces NSAID-induced gastric pathology (abst–2011) http/www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/807.1?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional
constipation (abst–2011) https://www.ncbi.nlm.nih.gov/pubmed/21045817
Abnormal anandamide metabolism in celiac disease (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22209002

Role of cannabinoid receptors and RAGE in inflammatory bowel disease (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21472688/abstract/Role_of_cannabinoid_receptors_and_RAGE_in_inflammatory_bowel_disease_
Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis (full-2012) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0052921
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility (full–2012) http/content.karger.com/produktedb/produkte.asp?DOI=000339072&typdf
The JNK inhibitor XG-102 protects against TNBS-induced colitis (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3302790/
Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility (full–2012) http/www.jneurosci.org/content/32/30/10331.long
Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3548934/
Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3372737/
Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome (full-2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3362100/
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3417459/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff- 857201f5e069
Gut microbiota and the development of obesity (full–2012) http/scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000500007&lng=en&nrm=iso&tlng=en
Over-Expression of Monoacylglycerol Lipase (MGL) in Small Intestine Alters
Endocannabinoid Levels and Whole Body Energy Balance, Resulting in Obesity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429419/
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice (full–2012) http/www.jleukbio.org/content/91/6/911.full
Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22269477
top
The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention (abst–2012) http/www.sciencedirect.com/science/article/pii/S1043661812000540
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22917662
Agents that act luminally to treat diarrhoea and constipation (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22945441
The effects of fasting duration on gastric emptying in man, an exploration of the role of
the endocannabinoid system and inter-individual responsiveness (abst–2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2012.01954.x/full
Endocannabinoid modulation of jejunal afferent responses to LPS (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22734449
Induction of Glucose Intolerance by Acute Administration of Rimonabant (abst–2012) https://www.karger.com/Article/Abstract/337731
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full-2013)  http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease (full-2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062078
Role of endogenous cannabinoid system in the gut (full-2013) http/www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
Effect of high fat-diet and obesity on gastrointestinal motility (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3890396/
Cannabis Finds Its Way into Treatment of Crohn’s Disease (full–2013) http/www.karger.com/Article/Pdf/356512
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3602676/
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3874007/
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract (full–2013) http/www.jpp.krakow.pl/journal/archive/04_13/pdf/167_04_13_article.pdf
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3677091/
Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3657109/
A potential role for GPR55 in gastrointestinal functions (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3660623/
Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23648372
Acute Δ9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23769745
Marijuana use patterns among patients with inflammatory bowel disease (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126607/
Industrial hemp decreases intestinal motility stronger than indian hemp in mice (link to PDF–2013) http/www.europeanreview.org/article/3266
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0006295213000543
The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and
increases intestinal transit in mice (abst–2013)  http://onlinelibrary.wiley.com/doi/10.1111/nmo.12158/full
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23454360
Interrogating Therapeutic Manipulation of the Endocannabinoid System in Human Colon (abst–2013) http/www.fasebj.org/cgi/content/meeting_abstract/26/1_MeetingAbstracts/1123.1?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23706402
top

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23849204
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoidmediated gastroprotective effect in rats (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/24145131
Magnolol inhibits colonic motility through down-regulation of voltage-sensitive L-type Ca(2+) channels of colonic smooth muscle cells in rats (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23972358
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24238999
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24275607
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation (abst–2013) http/onlinelibrary.wiley.com/doi/10.1111/jgh.12346/abstract
The regulation of food intake by the gut-brain axis: implications for obesity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22710925
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces
leukocyte adhesion and improves capillary perfusion in the gut (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23382309
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium (full–2014) http/ajpgi.physiology.org/content/307/2/G140
Modulation of Gut-Specific Mechanisms by Chronic Δ9-THC Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24400995
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25205418
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25275313
GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25348153
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25378491
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24460851
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24818658
Palmitoylethanolamide Regulates Development of Intestinal Radiation Injury in a Mast Cell-Dependent Manner (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213290/
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25263804
Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastro-Intestinal Motility and Improves Postprandial Glycemia in Mice (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25281429
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25531553
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N palmitoylethanolamine levels and counteracts murine colitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25384424
IBD patients find symptom relief in the Cannabis field (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947743/
Medical Marijuana for Digestive Disorders: High Time to Prescribe? (1st page–2014) (needs registration) http://www.medscape.com/viewarticle/839801 (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/25199471
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24444427
top
Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24631413
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24813296
The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuroneuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24911079
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst-2014) http/onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
Gut microbiota and obesity: Role in aetiology and potential therapeutic target (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25194177
Colitis generates remote antinociception in rats: the role of the L arginine / NO / cGMP / PKG / KATP pathway and involvement of cannabinoid and opioid systems (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25286904
Role of orphan G protein-coupled receptor 55 in diabetic gastroparesis in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24964851
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like
receptor 4-dependent PPAR-α activation (abst–2014)  http://gut.bmj.com/content/63/8/1300.abstract?sid=a8fb2a13-4493-4045-8855-9a0bae1e5d51
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/24407485
Toward modulation of the endocannabinoid system for treatment of gastrointestinal
disease: FAAHster but not “higher” (abst–2014)  http://onlinelibrary.wiley.com/doi/10.1111/nmo.12329/full
Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the
treatment of irritable bowel syndrome (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0960894X14012578
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26075589
Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [F]MK-9470 PET Study (full–2015) http://www.karger.com/Article/FullText/375454
top

No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects (full–2015)
http://www.turkjgastroenterol.org/sayilar/281/buyuk/639-43.pdf
Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382707/
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility (full–2015) http://www.casereports.com/article/S2210-2612%2815%2900219-9/pdf
Pharmacogenetics in irritable bowel syndrome (full – 2015) http://informahealthcare.com/doi/pdf/10.1517/17425255.2015.1048223
Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i37/10704.htm
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144270
Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556478/
Self-medication of achalasia with cannabis, complicated by a cannabis use disorder (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i20/6381.htm
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25505251
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway (full–2015) http://www.jbc.org/content/290/5/2902.long
Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25757568
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572435
Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600392/
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684407
The GPR55 antagonist CID16020046 protects against intestinal inflammation (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26227635
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918633/
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101681/
Endocannabinoid signaling at the periphery: 50 years after THC (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420685/
Gastric mucosal protection: from the periphery to the central nervous system (link to PDF–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25869205
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26254701
Cannabis – therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_14
The long-term functional consequences of acute infectious diarrhea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26628101
The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638765
Endocannabinoids – at the crossroads between the gut microbiota and host metabolism (abst–2015) http://www.nature.com/nrendo/journal/v12/n3/full/nrendo.2015.211.html
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26422462
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in
visceral and somatosensory pain regulatory pathways (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0014488615300959
Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids (full–2016) http://www.sciencedirect.com/science/article/pii/S1995764516300712
Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919975/
Unusual side effect of cannabis use: acute abdomen due to duodenal perforation (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936980/
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing
and inhibits neutrophil recruitment (full–2016) http://journal-inflammation.biomedcentral.com/articles/10.1186/s12950-016-0129-0
Endocannabinoids in the Gut (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940133/
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review
of the Literature (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040794/
The CB2 receptor and its role as a regulator of inflammation (full–2016)  http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental
colitis is related to inhibition of p38MAPK (full–2016) http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
Longitudinal examination of the intestinal lamina propria cellular compartment of SIV infected rhesus macaques provides broader and deeper insights into the link between
aberrant microRNA expression and persistent immune activation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859716/
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates
Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse (full-2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047908/
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological
Targets and Novel Treatments (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056566/
The role of the endocannabinoid system in the brain-gut axis (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/
Endocannabinoids in the gastrointestinal tract (full–2016)  http://ajpgi.physiology.org/content/311/4/G655.long
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain:
New insights and future perspectives (full–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26817719
Role of cannabinoids in gastrointestinal mucosal defense and inflammation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333598/
Endocannabinoids in the gastrointestinal tract (full–2016)  http://ajpgi.physiology.org/content/311/4/G655.long
Cannabis intake and intussusception: an accidental association? (download–2016) Cannabis intake and intussusception: an accidental association?
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome (full–2016) http://www.jlr.org/content/early/2016/02/17/jlr.M066308.long
Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization? (link to PDF–2016) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4045
Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes (full–2016) http://jpet.aspetjournals.org/content/early/2016/03/21/jpet.116.232553.long
top
Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26991932
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115 Endocannabinoids in the gut (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27538961
The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561826
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27579692
Determination of cannabinoids in hemp nuts products in Taiwan by HPLC-MS/MS coupled with chemometric analysis: Quality evaluation and a pilot human study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27590030
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623929 Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signalling in macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302499
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686064
Cannabinoids and GI Disorders: Endogenous and Exogenous (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27699625
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26561079
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
Application of carbon nanotubes as the carriers of the cannabinoid, 2- arachidonoylglycerol: Towards a novel treatment strategy in colitis (abst–2016) http://www.sciencedirect.com/science/article/pii/S002432051630666X
The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis (abst–2016) http://link.springer.com/article/10.1007%2Fs10620-016-4404-y
An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of
Jejunum on the Way to Unravel Her Hyperemesis Enigma (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/26757305
Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal
Dysmotility in the Rat (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00037/full
Bifidobacterium breve with α-linolenic acid alters the composition, distribution and
transcription factor activity associated with metabolism and absorption of fat (full–2017) http://www.nature.com/articles/srep43300
We are not alone: a case for the human microbiome in extra intestinal diseases (full–2017) https://gutpathogens.biomedcentral.com/articles/10.1186/s13099-017-0163-3
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis
Pathophysiology? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337874/
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process
induced by Clostridium difficile toxin A in Caco-2 cells (full–2017)  http://journals.sagepub.com/doi/full/10.1177/2050640617698622
Endocannabinoid system acts as a regulator of immune homeostasis in the gut (full–2017) http://www.pnas.org/content/early/2017/04/18/1612177114.long
Host-probiotic interaction: new insight into the role of the endocannabinoid system by in
vivo and ex vivo approaches (full–2017) https://www.nature.com/articles/s41598-017-01322-1
Interactions between gut microbes and host cells control gut barrier and metabolism  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485881/
Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipid dependent gut transit in ApoE-/- mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464855/
Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-
Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis
Extracts (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627671/
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation
and Pain (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688117/
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process
induced by Clostridium difficile toxin A in Caco-2 cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721977/
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and
prebiotics (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655955/
Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid
system protects against colitis and ameliorates remote organ lesions in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740744/
Modulation of the endocannabinoid system by the fatty acid amide hydrolase,
monoacylglycerol and diacylglycerol lipase inhibitors as an attractive target for secretory diarrhoea therapy (click “Full Text Link” for download-2017)  https://www.ncbi.nlm.nih.gov/pubmed/29151076
Role of cannabis in digestive disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27792038
Textual research on Han-Chinese formulae collected in Tubo medical manuscript unearthed in ‘Bum-pa-Che Tower (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28103984
Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28215162
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and
Therapeutic Relevance (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/28161834
Cannabinoids as gastrointestinal anti-inflammatory drugs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28239924
Nutritional status dependent endocannabinoid signalling regulates the integration of rat
visceral information (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28233325
G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn’s
disease and ulcerative colitis (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/00365521.2017.1298834?journalCode=igas20
The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0376871617300881
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn’s Disease, a
Randomized Controlled Trial (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28349233
The role of CB1 in intestinal permeability and inflammation (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28404744
MAGL inhibition modulates gastric secretion and motility following NSAID exposure in
mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28478068
The development of functional gastrointestinal diseases: Genetic aspects (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28635880
Pharmacogenetics and the treatment of functional gastrointestinal disorders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28686075
Impact of dietary fat on gut microbiota and low-grade systemic inflammation:
mechanisms and clinical implications on obesity (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/09637486.2017.1343286?journalCode=iijf20
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1
simultaneously to modulate colonic motility and visceral sensation in the mouse: A
pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28695708
Cannabidiol and Palmitoylethanolamide are anti-inflammatory in the acutely inflamed
human colon (abst–2017)  http://www.clinsci.org/content/early/2017/09/26/CS20171288.long
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes,
hippocampal neuroglial reorganization and depression in mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28890155
Endocannabinoid-related compounds in gastrointestinal diseases (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28990365
Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29313885


BRAIN*+
Alterations in the hippocampal endocannabinoid system in diet-induced obese mice (full-2010) http://www.jneurosci.org/content/30/18/6273.long
Disposition of Cannabichromene, Cannabidiol, and Δ9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023979/
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.00787.x/full
Endocannabinoid signalling: has it got rhythm? (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931554/
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033984/
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new
neurons in adult hippocampal neurogenesis (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic
Unpredictable Stress (full-2010)  http://www.nature.com/npp/journal/v35/n11/full/npp201099a.html
Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and
humans (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909018/
Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington
Disease In Vivo (full–2010) http://jnm.snmjournals.org/cgi/content/full/51/9/1413
Cyclooxygenase-2 Mediates Anandamide Metabolism in the Mouse Brain (full–2010) http://jpet.aspetjournals.org/content/335/2/380.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon  terminals in the hippocampus (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882293/pdf/nihms200194.pdf
Hypothalamic regulation of bone (full–2010) http://jme.endocrinology-journals.org/cgi/content/full/45/4/175
CB2: a cannabinoid receptor with an identity crisis (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931549/?tool=pubmed
Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers (full–2010)  https://academic.oup.com/ijnp/article/13/8/1103/809017
The development of cannabinoid CBII receptor agonists for the treatment of central
neuropathies (link to download–2010) http://www.eurekaselect.com/85808/article
The Role of Cannabinoid Receptors in the Descending Modulation of Pain (link to PDF-2010) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.634.4866&rank=72
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study  (link to download–2010)  https://www.researchgate.net/publication/46306066_Does_intravenous_D9-
tetrahydrocannabinol_increase_dopamine_release_A_SPET_study
A model of endocannabinoid 2-AG-mediated depolarization-induced suppression of
inhibition (article–2010) http://www.biomedcentral.com/content/pdf/1471-2202-11-S1-P189.pdf
Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids (abst–2010) https://www.ncbi.nlm.nih.gov/pubmed/20085790 Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat (abst-2010) http://journals.sagepub.com/doi/full/10.1111/j.1468-2982.2009.01924.x
Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased
brain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353771
Dopamine modulation of excitatory currents in the striatum is dictated by the expression
of D1 or D2 receptors and modified by endocannabinoids (abst–2010)
http://www.ncbi.nlm.nih.gov/pubmed/20092552
In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model
of Parkinson’s disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20026090
Cannabinoids modulate hippocampal memory and plasticity (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/19830813
Brain cannabinoid CB2 receptor in schizophrenia (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/19931854
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting
neutrophil recruitment (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19884325
Comparison of Cannabinoid CB1 Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [18F]MK-9470 (full-2011) http://www.hindawi.com/journals/ijmi/2011/548123/
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in
the mouse brain: an intravital microscopy study (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
N-Docosahhexanoyllethanolamide promotes development of hippocampal neurons (full–2011) http://www.biochemj.org/content/435/2/327
Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress (full–2011) http://cercor.oxfordjournals.org/content/21/9/2056.full
Endocannabinoid modulation of sympathetic and cardiovascular responses to acute stress in the periaqueductal gray of the rat (full–2011)  http://ajpregu.physiology.org/content/300/3/R771
Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and
Cannabidiol: an fMRI Study (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096803/
Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137184/
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity  (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388033/
Brain cannabinoid CB2 receptors modulate cocaine’s actions in mice (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164946/
Cannabinoid receptor expression in HIV encephalitis and HIV-associated
neuropathologic comorbidities (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135748/
Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of
Pilocarpine-Induced Epilepsy (full–2011)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0027196
Sex difference in cell proliferation in developing rat amygdala mediated by
endocannabinoids has implications for social behavior (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?tool=pubmed
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181427/pdf/fnbeh-05-00064.pdf
Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations:
alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol) (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033515/?tool=pmcentrez
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by
Δ9-THC administration into the medial prefrontal cortex (full–2011)  http://www.sciencedirect.com/science/article/pii/S0006899311001533
Pharmacological elevation of anandamide impairs short-term memory by altering the
neurophysiology in the hippocampus (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156972/
Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making  (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260974/
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210336/
Comparative effects of chlorpyrifos in wild type and cannabinoid Cb1 receptor knockout
mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205254/
Effect of Developmental Chlorpyrifos Exposure on Endocannabinoid Metabolizing
Enzymes in the Brain of Juvenile Rats (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143466/
The role of cannabinoids in modulating emotional and non-emotional memory processes
in the hippocampus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124830/?tool=pubmed
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01467.x/full
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical
Framework for Both Adverse and Therapeutic Effects of Cannabis Use (full–2011)  http://www.hindawi.com/journals/sprt/2011/501726/
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085576/
Cannabinoid exposure during zebra finch sensorimotor vocal learning persistently alters
expression of endocannabinoid signaling elements and acute agonist responsiveness  (full–2011) http://www.biomedcentral.com/1471-2202/12/3
Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde
synaptic depression in the cerebellum (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224879/
Complementary synaptic distribution of enzymes responsible for synthesis and
inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus  (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678284/
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21640532/abstract/Effects_of_synthetic_cannabinoids_on_electroencephalogram_power_spectra_in_rats_
Intermittent ethanol consumption depresses endocannabinoid-signaling in the dorsolateral striatum of rat (abst–2011) http://www.sciencedirect.com/science/article/pii/S0028390811000177
Intact cannabinoid CB1 receptors in the Alzheimer’s disease cortex (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0197018610003232
Early exposure to Environmental enrichment alters the expression of genes of the
endocannabinoid system (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21419109/abstract/Early_exposure_to_Environmental_enrichment_alters_the_expression_of_genes_of_the_endocannabinoid_system_
Cannabinoid receptor expression and phosphorylation are differentially regulated
between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0304394011006033
Metabolic and Type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21459091/abstract/Metabolic_and_Type_1_cannabinoid_receptor_imaging_of_a_transgenic_rat_model_in_the_early_phase_of_Huntington_disease_
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition
by phthalate esters in vitro (abst-2011)  http://www.sciencedirect.com/science/article/pii/S0197018611002269
Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a
phenotype-, compound-, dose-, and region-specific manner (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21645556/abstract/%CE%94_9__THC_and_WIN55212_2_affect_brain_tissue_levels_of_excitatory_amino_acids_in_a_phenotype__compound__dose__and_region_specific_manner_
Regional changes in type 1 cannabinoid receptor availability in Parkinson’s disease in
vivo (abst–2011) https://www.ncbi.nlm.nih.gov/pubmed/21459482
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism:
preclinical Parkinson disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20862500
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine
Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions (abst–2011) https://www.ncbi.nlm.nih.gov/pubmed/21265596
Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral
ischemia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21443454
Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and
functionality in female rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21145311
Temporal changes in N-acylethanolamine content and metabolism throughout the periadolescent period (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510355/
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572464/
Neural Circuit in the Dorsal Raphe Nucleus Responsible for Cannabinoid-Mediated Increases in 5-HT Efflux in the Nucleus Accumbens of the Rat Brain (full–2012) http://www.hindawi.com/isrn/pharmacology/2012/276902/
Review article: The endocannabinoid system in normal and pathological brain ageing  (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently (full–2012) http://ijnp.oxfordjournals.org/content/16/2/393.long
Multiple functions of endocannabinoid signaling in the brain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22524785?dopt=Abstract
CHRONIC, NONINVASIVE GLUCOCORTICOID ADMINISTRATION SUPPRESSES LIMBIC ENDOCANNABINOID SIGNALING IN MICE (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697830/
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full–2012)  http://www.jneuroinflammation.com/content/9/1/10
Hypothalamic CB1 Cannabinoid Receptors Regulate Energy Balance in Mice (full–2012) http://press.endocrine.org/doi/full/10.1210/en.2012-1405
Cannabinoid Receptor CB2 Modulates Axon Guidance (link to PDF-2012) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.727.7765&rank=63&q=cannabinoid&osm=&ossid=
2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism  (full–2012) http://www.sciencedirect.com/science/article/pii/S1550413112000526
The thrifty lipids: endocannabinoids and the neural control of energy conservation (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744874/
Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268782/
Neuron to Astrocyte Communication via Cannabinoid Receptors Is Necessary for
Sustained Epileptiform Activity in Rat Hippocampus (full–2012)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037320
Epileptiform activity in the CA1 region of the hippocampus becomes refractory to
attenuation by cannabinoids in part because of endogenous γ-aminobutyric acid type B
receptor activity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350599/
Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase –
Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480564/
Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington’s disease and mouse models (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699342/
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical
development (full–2012)  http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset
and Severity in Mouse Models of Huntington’s Disease (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753072/
The periaqueductal gray contributes to bidirectional enhancement of antinociception
between morphine and cannabinoids (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959123/
Functional connectivity in brain networks underlying cognitive control in chronic
cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376324/
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation
of hippocampal LTD (full–2012) http://www.cell.com/cell/fulltext/S0092-8674(12)00142-0
Long-lasting potentiation of hippocampal synaptic transmission by direct cortical input is mediated via endocannabinoids (full–2012)  http://jp.physoc.org/content/590/10/2305.full
Dietary conditions and highly palatable food access alter rat cannabinoid receptor
expression and binding density (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621143/
The decrease of dopamine D(2)/D(3) receptor densities in the putamen and nucleus
caudatus goes parallel with maintained levels of CB(1) cannabinoid receptors in
Parkinson’s disease: A preliminary autoradiographic study with the selective dopamine
D(2)/D(3) antagonist [(3)H]raclopride and the novel CB(1) inverse agonist [(125)I]SD7015 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180092/
Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2
after neonatal stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446851/
Placebo-induced improvements: how therapeutic rituals affect the patient’s brain (full–2012) http://www.jams-kpi.com/article/S2005-2901%2812%2900031-3/fulltext
Convergent translational evidence of a role for anandamide in amygdala-mediated fear
extinction, threat processing and stress-reactivity (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549323/
Cortical basket cell dysfunction in schizophrenia (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381305/
Brain regional differences in CB1 receptor adaptation and regulation of transcription
(full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772765/
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in
patients with schizophrenia (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463751/
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375509/
Alelle specific differences in the activity of a novel cannabinoid receptor 1(CNR1) gene
intronic enhancer in hypothalamus, dorsal root ganglia and hippocampus (full–2012)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339935/
The Endocannabinoid System and the Brain (link to PDF–2012)  https://www.researchgate.net/publication/229163258_The_Endocannabinoid_System_and_the_Brain
Mitochondrial CB(1) receptors regulate neuronal energy metabolism (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22388959
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22391102
Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18F-FDG (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22155282
Manipulating brain connectivity with δ(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22885247
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated Stress on (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23200786
Impaired hippocampal glucoregulation in the cannabinoid CB(1) receptor knockout mice as revealed by an optimized in vitro experimental approach (abst-2012) http://www.sciencedirect.com/science/article/pii/S0165027011007059
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury (abst–2012) http://www.sciencedirect.com/science/article/pii/S1043661812001636
top
Cannabinoid modulation of mother-infant interaction: is it just about milk? (abst–2012)  http://www.degruyter.com/abstract/j/revneuro.2012.23.issue-5-6/revneuro-2012-0074/revneuro-2012-0074.xml?rskey=wRYgJd&result=1&q=cannabinoid
Effect of delta-9-tetrahydrocannabinol on behavioral despair and on presynaptic and
postsynaptic serotonergic transmission (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22386778
Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a
lean phenotype in adult mice (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22487302
The inverse agonist effect of rimonabant on G protein activation is not mediated by the
cannabinoid CB1 receptor: Evidence from postmortem human brain (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0006295211008161
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in
animals (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22807156
Effects of Δ9-Tetrahydrocannabinol Administration on Human Encoding and Recall
Memory Function: A Pharmacological fMRI Study (abst–2012)  http://www.mitpressjournals.org/doi/abs/10.1162/jocn_a_00156?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&#.Va6zXvlwtB8
Diet-dependent modulation of hippocampal expression of endocannabinoid signaling related proteins in cannabinoid antagonist-treated obese rats (abst–2012)
http://www.ncbi.nlm.nih.gov/pubmed/23033907
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor
signaling pathway in the brain and associated anxiety-like behavior in mice (abst–2012) http://www.springerlink.com/content/ur5784gm34782505/
Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22841538
Increased gray matter density in patients with schizophrenia and cannabis use: A voxel based morphometric study using DARTEL (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0920996412001740
Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain
damage in middle cerebral artery occluded rats and non-human primates (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22119394
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic
injury by activating peroxisome proliferator-activated receptor α (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0028390812001062
The Effect of Cannabis on Perception of Time (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22716134
Pharmacological inhibition of endocannabinoid degradation modulates the expression of
inflammatory mediators in the hypothalamus following an immunological stressor  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21952131
Mechanism of the Interaction of Cannabinoid System in Central Amygdale with Opioid
System (abst–2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=139101
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537620/
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058926
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses (full–2013) http://www.pnas.org/content/early/2013/03/06/1211204110.full.pdf+html
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies (full–2013) http://www.karger.com/Article/FullText/350094
Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629308/
Acute and chronic administration of cannabidiol increases mitochondrial complex and
creatine kinase activity in the rat brain (full–2013) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462013000400380&lng=en&nrm=iso&tlng=en
The anxiolytic effect of cannabidiol on chronically stressed mice depends on
hippocampal neurogenesis: involvement of the endocannabinoid system (full–2013) http://ijnp.oxfordjournals.org/content/16/6/1407.long
Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum
Disorders (full–2013)  http://www.sciencedirect.com/science/article/pii/S0896627313003619
Multiple sclerosis and the blood-central nervous system barrier (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the
hypothalamus (full–2013) http://joe.endocrinology-journals.org/content/219/1/79.long
Epigenetics, drugs of abuse, and the retroviral promoter (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878082/
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory
neurodegeneration in multiple sclerosis (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
CB1 Receptor-Mediated Signaling Underlies the Hippocampal Synaptic, Learning and
Memory Deficits Following Treatment with JWH-081, a New Component of Spice/K2
Preparations (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959795/
Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse
brain mitochondria (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902808/
Stimulatory and Inhibitory Roles of Brain 2-Arachidonoylglycerol in Bombesin-Induced
Central Activation of Adrenomedullary Outflow in Rats (full–2013)  https://www.jstage.jst.go.jp/article/jphs/121/2/121_12208FP/_pdf
Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible
structure-specific plasticity process in 6-OHDA lesioned rats (full–2013)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076874
Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus  (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12137/full
Diacylglycerol Lipaseα (DAGLα) and DAGLβ Cooperatively Regulate the Production of
2-Arachidonoyl Glycerol in Autaptic Hippocampal Neurons (full–2013)  http://molpharm.aspetjournals.org/content/84/2/296.full.pdf+html
Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes  (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854987/
Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator
sensitive to cannabinoids and opioids in hippocampal CA1 (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903354/
Induction of Endocannabinoid Levels in Juvenile Rat Brain Following Developmental
Chlorpyrifos Exposure (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954109/
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission
Associated with Olanzapine-Induced Weight Gain (full–2013)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033548
Amygdala activity contributes to the dissociative effect of cannabis on pain perception  (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549497/
ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a
murine model of the neurodegenerative disease PHARC (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557017/
Comparative effects of parathion and chlorpyrifos on extracellular endocannabinoid
levels in rat hippocampus: Influence on cholinergic toxicity (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831619/
Low Level Chlorpyrifos Exposure Increases Anandamide Accumulation in Juvenile Rat
Brain in the Absence of Brain Cholinesterase Inhibition (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071163/
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a
positron emission tomography study (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752332/
Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by
Facilitating the Degradation of Endocannabinoid 2-AG (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776056/
Brain Region-Specific Changes in N-Acylethanolamine Contents with Time of Day (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12495/full
DGLα and DGLβ Cooperatively Regulate the Production of 2-arachidonoyl Glycerol in
Autaptic Hippocampal Neurons (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716324/
The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in
cytokine expression in the rat frontal cortex and plasma: differential mechanisms of
action (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687661/
Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to download–2013) http://www.eurekaselect.com/107948/article
Biosynthetic Pathways of Bioactive N-Acylethanolamines in Brain (link to PDF–2013) http://www.eurekaselect.com/107971/article
Correspondence (letter to the editor): Cannabis Therapy (letter–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601285/
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2
Receptor Ligand [11C]-NE40 in Healthy Subjects (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23508466
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22763024
Changes in cannabinoid CB1 receptor functionality in the female rat prefrontal cortex following a high fat diet (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454443
Imaging dopamine transmission parameters in cannabis dependence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24513022
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23020923
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists (abst–2013) http://pubs.acs.org/doi/abs/10.1021/jm4005626
The regulation of food intake by the gut-brain axis: implications for obesity (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/22710925
Endogenous cannabinoids in amygdala and hippocampus in post-mortem brains of
Cloninger type 1 and 2 alcoholics (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23747173
The CB1 cannabinoid receptor mediates glucocorticoid-induced effects on behavioural
and neuronal responses during lactation (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23417606
Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23562616
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects  (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23800614
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit
neuroinflammation and apoptosis after neonatal ischemic brain damage (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23376684
Developmentally-induced hypothyroidism alters the expression of Egr-1 and Arc genes
and the sensitivity to cannabinoid agonists in the hippocampus. Possible implications for
memory and learning (abst–2013)  http://www.sciencedirect.com/science/article/pii/S030372071200456X
Emotional, endocrine and brain anandamide response to social challenge in infant male
rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23660109
DHA prevents altered 5-HT1(A), 5-HT2(A), CB1 and GABA(A) receptor binding densities in the brain of male rats fed a high-saturated-fat diet (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23337348
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin
concentrating hormone neurons in rats (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0091305713001007
Glutamate spillover drives endocannabinoid production and inhibits GABAergic
transmission in the Substantia Nigra pars compacta (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0028390813005790
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23669059
L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1)
cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0028390813005121
Endocannabinoids mediate hyposalivation induced by inflammogens in the  submandibular glands and hypothalamus (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23684250
Dominant negative DISC1 mutant mice display specific social behaviour deficits and
aberration in BDNF and cannabinoid receptor expression (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24219803
The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia dependent neuroprotection after excitotoxic lesion (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24038453
Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist
TM38837 in comparison with rimonabant in nonhuman primates: A PET study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24293119
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders (full–2014) http://jpn.ca/wp-content/uploads/2014/12/39-6-140081.pdf
Cocaine-Induced Behavioral Sensitization Is Associated With Changes in the Expression of Endocannabinoid and Glutamatergic Signaling Systems in the Mouse Prefrontal Cortex (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25539508
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self Administration in Mice and Rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25374096
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models (full–2014) http://www.nature.com/tp/journal/v4/n5/full/tp201431a.html
Endocannabinoid signalling and the deteriorating brain (abst–2014) http://www.nature.com/nrn/journal/v16/n1/abs/nrn3876.html
Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy
Expenditure in Male Mice (full–2014) http://press.endocrine.org/doi/10.1210/en.2014-1437
Role of oleoylethanolamide as a feeding regulator in goldfish (full–2014)  http://jeb.biologists.org/content/217/15/2761
The Novel Endocannabinoid Receptor GPR18 is Expressed in the Rostral Ventrolateral
Medulla and Exerts Tonic Restraining Influence on Blood Pressure (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965889/
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional
Memory Formation via Functional Interactions with the Ventral Tegmental Area (full–2014) http://www.jneurosci.org/content/34/39/13096.long
Astrocytic expression of cannabinoid type 1 receptor in rat and human sclerotic
hippocampi (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097232/
Endocannabinoid Signaling within the Basolateral Amygdala Integrates Multiple Stress
Hormone Effects on Memory Consolidation (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397407/
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing
Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferator activated Receptor β/δ (PPARβ/δ) in the Brain (full–2014)  http://www.jbc.org/content/289/18/12748.long
Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis use Interact on
Prefrontal Connectivity and Related Working Memory Behavior (full–2014)  http://www.nature.com/npp/journal/v40/n3/full/npp2014213a.html
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor
KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (full–2014)  http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.12298
Aberrant Location of Inhibitory Synaptic Marker Proteins in the Hippocampus of
Dystrophin-Deficient Mice: Implications for Cognitive Impairment in Duchenne
Muscular Dystrophy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178163/
Cannabinoid receptors contribute to astroglial Ca2+-signalling and control of synaptic
plasticity in the neocortex (full–2014)  http://rstb.royalsocietypublishing.org/content/369/1654/20140077.long
Individual differences in response to positive and negative stimuli: endocannabinoid based insight on approach and avoidance behaviors (full–2014)  http://journal.frontiersin.org/Journal/10.3389/fnsys.2014.00238/full
Control of Inhibition by the Direct Action of Cannabinoids on GABAA Receptors (full–2014) http://cercor.oxfordjournals.org/content/early/2014/03/18/cercor.bhu045.long
Morphological and Behavioural Evidence for Impaired Prefrontal Cortical Function in
Female CB1 Receptor Deficient Mice (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128323/
Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the
periaqueductal grey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294036/
Developmental Increase in Hippocampal Endocannabinoid Mobilization: Role of
Metabotropic Glutamate Receptor Subtype 5 and Phospholipase C (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233278/
Endocannabinoids in Synaptic Plasticity and Neuroprotection (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143501/
Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission (full-2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398527/
Long-term changes in the ghrelin-CB1R axis associated with the maintenance of lower
body weight after sleeve gastrectomy (full–2014)  http://www.nature.com/nutd/journal/v4/n7/full/nutd201424a.html
The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944632/
CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain
neurotensin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016688/
Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine
Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332795/
Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and
degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins
calbindin, calretinin, and parvalbumin in the adult rat hippocampus (full–2014)
http://journal.frontiersin.org/Journal/10.3389/fnana.2014.00056/full
Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats
and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201088/
Expression and localization of cannabinoid receptor 1 in rats’ brain treated with acute and repeated morphine (link to PDF–2014) http://www.ncbi.nlm.nih.gov/pubmed/25231848
Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially
modulates contextually induced fear, depending on a persistent pain state (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494683
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25452006
The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic
subjects (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/adb.12160/abstract
Cannabinoid type-1 Receptors in The Paraventricular Nucleus of The Hypothalamus
Inhibit Stimulated Food Intake (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24434770
Imaging dopamine transmission parameters in cannabis dependence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24513022
Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0168010214000716
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents
the increase in REMS and food ingestion induced by PAR1 stimulation (abst–2014) http://www.sciencedirect.com/science/article/pii/S0304394014005229
The role of gut hormones in appetite regulation (review) (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25532952
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced
antinociception and cannabinoid receptor binding in the female rat (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0091305714001774
Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A
activity in vivo in R6/2 Huntington mice (abst–2014)  http://www.neurobiologyofaging.org/article/S0197-4580(14)00429-1/fulltext
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and
oxidative stress linked to excitotoxicity in the rat brain (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25446347
Endocannabinoid-mediated retrograde modulation of synaptic transmission (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN)
via astrocytes (abst–2014) http://link.springer.com/article/10.1007%2Fs00429-014-0842-5
Cannabinoid-mediated short-term plasticity in hippocampus (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25123173
Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide
and 2-AG in the hippocampus (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25087967
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s
disease (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0304394014009318
Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory
activity in the thalamus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508153
Role of the basolateral amygdala in mediating the effects of the fatty acid amide
hydrolase inhibitor URB597 on HPA axis response to stress (abst–2014)  http://www.europeanneuropsychopharmacology.com/article/S0924-977X(14)00202-8/fulltext
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey
striatum (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0014488614002040
Brain regional cannabinoid CB1 receptor signalling and alternative enzymatic pathways
for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient
mice (abst–2014) http://www.sciencedirect.com/science/article/pii/S0928098713003497
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey
striatum. (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24967683
Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [F]MK-9470 PET Study (full–2015)
http://www.karger.com/Article/FullText/375454
Role of dopamine type 1 receptors and DARPP-32 in Δ9-THC-mediated induction of ΔFosB in the mouse forebrain (full–2015)
http://jpet.aspetjournals.org/content/early/2015/06/22/jpet.115.224428.long
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action. (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900725-1
Combined effects of marijuana and nicotine on memory performance and hippocampal volume (full–2015) http://www.sciencedirect.com/science/article/pii/S0166432815301005
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25632127
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling (full–2015) http://www.mdpi.com/2076-3425/5/4/456/htm
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640353/ 
top

Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00457/full
Cannabinoid receptor activation in the juvenile rat brain results in rapid biomechanical alterations: Neurovascular mechanism as a putative confounding factor (full–2015) http://jcb.sagepub.com/content/early/2015/09/23/0271678X15606923.long
Impact of CB1 Receptor Deletion on Visual Responses and Organization of Primary Visual Cortex in Adult Mice (full–2015) http://iovs.arvojournals.org/article.aspx?articleid=2474494&resultClick=1
Neural correlates of cannabidiol and Δ9-tetrahydrocannabinol interactions in mice: implications for medical cannabis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13333/full
Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume (full–2015) http://ijnp.oxfordjournals.org/content/18/10/pyv061 Tetrahydrocannabivarin (THCv) reduces Default Mode Network and increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/09/10/ijnp.pyv092.long
Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder (full–2015) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-015-0104-3
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568004/
Developmental regulation of fear learning and anxiety behavior by endocannabinoids (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12253/full
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25650954
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604232/
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665616/ Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691436/
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25933444
Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532757/
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats (full–2015) http://www.jneurosci.org/content/35/41/13962.long Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition (full-2015) http://www.pnas.org/content/113/1/26.long
Mechanisms of stress in the brain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933289/
Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure (full–2015) http://jamanetwork.com/journals/jamapsychiatry/fullarticle/2429550
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917208/
A Hardwired Circuit Supplemented with Endocannabinoids Encodes Behavioral Choice in Zebrafish (full–2015) http://www.cell.com/current-biology/fulltext/S0960-9822(15)01013-1
Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of
threat (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801124/
Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food Restricted Rats: Involvement of CB1 Receptors (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793114/
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (full–2015) http://www.hindawi.com/journals/mi/2015/523418/
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via
selective inhibition of its COX-2-mediated oxygenation (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490613/
Reduced Brain Cannabinoid Receptor Availability In Schizophrenia (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884543/
Brain Mapping-Based Model of Δ9-Tetrahydrocannabinol Effects on Connectivity in the
Pain Matrix (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832029/
Alterations in the Medullary Endocannabinoid System Contribute to Age-related
Impairment of Baroreflex Sensitivity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424182/
Epigenetic Effects of Cannabis Exposure (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789113/
Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A
review (full-2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294710/
Endocannabinoid signaling integrates multiple stress hormone effects on memory (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397407/
New horizons for newborn brain protection: enhancing endogenous neuroprotection  (full–2015) http://fn.bmj.com/content/100/6/F541
Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate Hippocampal Accumbens Plasticity after Stress (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748431/
Involvement of the infralimbic cortex and CA1 hippocampal area in reconsolidation of a
contextual fear memory through CB1 receptors: effects of CP55,940 (full–2015)  http://www.sciencedirect.com/science/article/pii/S1074742715002257
α/β Hydrolase Domain-Containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal
Lipid Bis(monoacylglycero)phosphate (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705992/
The Combined Inhibitory Effect of the Adenosine A1 and Cannabinoid CB1 Receptors
on cAMP Accumulation in the Hippocampus Is Additive and Independent of A1
Receptor Desensitization (full–2015)  http://www.hindawi.com/journals/bmri/2015/872684/
cnrip1 is a regulator of eye and neural development in Xenopus laevis (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/gtc.12225/full
VGluT3-Expressing CCK-Positive Basket Cells Construct Invaginating Synapses
Enriched with Endocannabinoid Signaling Proteins in Particular Cortical and Cortex-Like
Amygdaloid Regions of Mouse Brains (full–2015)  http://www.jneurosci.org/content/35/10/4215.long
Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse
Hippocampus (full–2015) http://www.jneurosci.org/content/35/9/3842.long
Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210 (full–2015)  http://www.biomolther.org/journal/view.html?volume=23&number=6&spage=597&year=2015
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid
type-1 (CB1 ) receptors located on glutamatergic neurons and on astrocytes (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13044/full
Simultaneous inhibition of fatty acid amide hydrolase (FAAH) and monoacylglycerol
lipase (MAGL) shares discriminative stimulus effects with ∆9-THC in mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407717/
Neurobiological Interactions Between Stress and the Endocannabinoid System (full–2015) http://www.nature.com/npp/journal/v41/n1/full/npp2015166a.html
HPLC-MS-MS Determination of ZCZ-011, A Novel Pharmacological Tool for
Investigation of the Cannabinoid Receptor in Mouse Brain Using Clean Screen FASt™
Column Extraction (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542657/
Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a
positron emission tomography study with the novel radioligand [11C]CURB (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635238/
Behavioral genetics: of mice, men, and internal bliss (full–2015)  http://www.cell.com/current-biology/fulltext/S0960-9822(15)00414-5
Changes Marijuana’s Effect on the Brain (abstract & news-2015)  http://neurosciencenews.com/hippocampal-volume-nicotine-marijuana-2457/
Simultaneous determination of endocannabinoids in murine plasma and brain  substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0731708515001946
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Age-related changes in the endocannabinoid system in the mouse hippocampus (abst–2015) http://www.sciencedirect.com/science/article/pii/S0047637415300099
The role of the Cannabinoid Receptor 1 in adolescents’ processing of facial expressions  (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26527537
The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25779032
Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815001264
Thalamic and Cerebellar Gray Matter Volume Reduction in Synthetic Cannabinoids Users (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26021304
Metabolome disruption of the rat cerebrum induced by the acute toxic effects of the synthetic cannabinoid MAM-2201 (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26032255
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at
Glutamatergic Synapses in the Rat Basolateral Amygdala (abst–2015)  http://www.sciencedirect.com/science/article/pii/S002839081530201X
Combined neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26065937
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26071625
Changes over time of cannabinoid receptor 1 in hippocampus of status epilepticus rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26168676
Strain and sex differences in puberty onset and the effects of THC administration on weight gain and brain volumes (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215006387
Sex differences in associations between cannabis craving and neural responses to cannabis cues: Implications for treatment (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26237321
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
The brain in bone and fuel metabolism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26545334
Δ9-Tetrahydrocannabinol (Δ9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques (abst–2015) http://link.springer.com/article/10.1007%2Fs11481-015-9645-6
The Role of the Brain’s Endocannabinoid System in Pain and Its Modulation by Stress (abst–2015) http://www.ncbi.n lm.nih.gov/pubmed/26638768
Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26663094
Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708672
The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats (abst–2015) http://link.springer.com/article/10.1007/s00580-014-1907-9
Intermittent access to liquid sucrose differentially modulates energy intake and related central pathways in control or high-fat fed mice (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/25484353
Functional interaction between the orexin-1 and CB1 receptors within the nucleus accumbens in the conditioned place preference induced by the lateral hypothalamus stimulation (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715000647
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal
cortex modulate anxiety-like behavior in rats: additional evidence (abst–2015)
http://www.sciencedirect.com/science/article/pii/S0278584615000068
CB1 receptors into the Prelimbic Cortex modulate food intake in rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0278584615000068
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and
cerebellum of alcoholic subjects (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/26253623
Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits
in a germinal matrix hemorrhage rat model (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25625355
Attenuation of kainic acid-induced status epilepticus by inhibition of endocannabinoid
transport and degradation in guinea pigs (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25769371
Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial
novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral
amygdala (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432814007323
Involvement of the serotonergic system of the ventral hippocampus (CA3) on amnesia
induced by ACPA in mice (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432815001552
Cannabinoids suppress acute and anticipatory nausea in pre-clinical rat models of
conditioned gaping (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25691302
Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic
Hippocampal Slice Cultures (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25645684
Emerging concepts of pain therapy based on neuronal mechanisms (abst–2015)  http://link.springer.com/chapter/10.1007%2F978-3-662-46450-2_1
Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide
synthase in rat brain hippocampus (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26115586
Excitatory drive from the subthalamic nucleus attenuates GABAergic transmission in the
Substantia Nigra pars compacta via endocannabinoids (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26472124
Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via
cannabinoid type-1 receptors (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26254729
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral  ventromedial medulla cell activity in mice (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0014299914008929
Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite
modulation on expression of contextual fear conditioning (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0028390815302161
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic
transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute
swim stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25581607
Stress-related synaptic plasticity in the hypothalamus (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26087679
Repeated administration of phytocannabinoid Δ9-THC or synthetic cannabinoids JWH018
and JWH-073 induces tolerance to hypothermia but not locomotor suppression in
mice, and reduces CB1 receptor expression and function in a brain region-specific
manner (abst–2015) http://www.sciencedirect.com/science/article/pii/S1043661815002108
Intra-visceral insular cortex 2-arachidonoylglycerol, but not arachidonoylethanolamide,
suppresses acute nausea-induced conditioned gaping in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25499318
Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of
CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol
lipase (abst–2015) http://www.sciencedirect.com/science/article/pii/S0928098715003000
Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25615413
Stimulation OF IN VIVO dopamine transmission and intravenous self-administration in
rats and mice by JWH-018, a Spice cannabinoid (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0028390815300861
A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor
antagonists in non-human primates (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0028390815000945
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following
germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815001574
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain (full–2016) http://www.hindawi.com/journals/np/2016/9247057/
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands (full–2016) http://www.hindawi.com/journals/np/2016/9815092/
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory (full–2016) http://www.hindawi.com/journals/np/2016/9817089/
GABABR-Dependent Long-Term Depression at Hippocampal Synapses between CB1- Positive Interneurons and CA1 Pyramidal Cells (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00004/full
GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149034
A collaboration investigating endocannabinoid signalling in brain and bone (full–2016) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0125/jbcpp-2015-0125.xml
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865651/
Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152482 Cannabinoid receptor type-1: breaking the dogmas (full–2016) http://f1000research.com/articles/5-990/v1
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907698/
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273%2816%2930157-X
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease (full–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300879
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids (full–2016) http://www.nature.com/articles/npjamd201612
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899060/
Synthetic cannabinoids revealing adrenoleukodystrophy (full–2016) http://www.sciencedirect.com/science/article/pii/S0967586815004567
Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983615/
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899471/
Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0257-8
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism (full–2016) http://www.jbc.org/content/early/2016/07/29/jbc.M116.746594.long
Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940392/
Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923145/
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid mediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0682-8 Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Vascular Dysfunction in a Transgenic Model of Alzheimer’s Disease: Effects of CB1R and CB2R Cannabinoid Agonists (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00422/full
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015205a.html
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00415/full
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review (full–2016) http://link.springer.com/article/10.1007%2Fs12035-016-0313-5
Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol Self Administration by Wistar Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152943/
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1878929316300639
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993868/
Components of the cannabinoid system in the dorsal periaqueductal gray are related to resting heart rate (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982395/
CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00210-016-1302-y
Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868450/
Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3 (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031696/
Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075776/
α/β-Hydrolase Domain 6 in the Ventromedial Hypothalamus Controls Energy Metabolism Flexibility (full – 2016) http://www.cell.com/cell-reports/fulltext/S2211-1247(16)31373-0 Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00429-016-1345-3
Alteration of SLP2‐like immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784115/
Hippocampal harms, protection and recovery following regular cannabis use (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015201a.html
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Lipids in psychiatric disorders and preventive medicine (full–2016)  http://www.sciencedirect.com/science/article/pii/S0149763415303353
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward
Regions (full–2016) https://www.ncbi.nlm.nih.gov/pubmed/27707960
Neural mechanisms of sensitivity to peer information in young adult cannabis users  (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955693/
Deficient adolescent social behavior following early-life inflammation is ameliorated by
augmentation of anandamide signaling (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461973/
Endocannabinoids in Cerebrovascular Regulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865067/
Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats  (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373702/
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study  (full–2016) http://www.nature.com/tp/journal/v6/n7/full/tp2016118a.html
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food
reward in male mice (full–2016) http://www.ncbi.nlm.nih.gov/pubmed/26873082
Brain circuitry associated with the development of substance use in bipolar disorder and
preliminary evidence for sexual dimorphism in adolescents (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123602/
Ovariectomy Alters Gene Expression of the Hippocampal Formation in Middle-Aged Rats (link to PDF–2016) http://press.endocrine.org/doi/10.1210/en.2016-1516?url_ver=Z39.88-2003&rfr_id=ori%3Arid %3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27806235
Protein purification and cloning of diacylglycerol lipase from rat brain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26790472
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26804027
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26946127
Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27021494
Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27063786
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27305347
The role of the endocannabinoid system in the brain-gut axis (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/
Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine
exposure (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743781/
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse – the probable role of
molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent –
case report (link to download–2016) http://www.mppt.hu/folyoirat/1/abstract/?vol=18&issue=3&elsooldal=162
Marijuana effects on changes in brain structure and cognitive function among HIV+ and
HIV- adults (full–2016) https://www.ncbi.nlm.nih.gov/pubmed/27889592
Fabp-1 gene ablation impacts brain endocannabinoid system in male mice (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961623/
Neural endocannabinoid CB1 receptor expression, social status, and behavior in male European starlings (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27206544
Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and (+/+)
mice (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937884/
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain
Endocannabinoid Levels (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418128/
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of
memory consolidation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024630/
Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by
the excess microglia-mediated inflammation (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931157/
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats (full–2016)  http://jnrbm.biomedcentral.com/articles/10.1186/s12952-016-0052-1
What failed BIA 10–2474 Phase I clinical trial? Global speculations and
recommendations for future Phase I trials (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020770/
Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain (full–2016)  http://journals.sagepub.com/doi/full/10.1177/0271678X16668890
The effects of Δ9-tetrahydrocannabinol on the dopamine system (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123717/
Cannabinoids in the Brain: New Vistas on an Old Dilemma (article–2016) http://www.hindawi.com/journals/np/2016/9146713/
Harvesting Benefits from Cannabinoids (article–2016) http://www.cell.com/cell/fulltext/S0092-8674(16)31675-0
Suppressing Schizophrenia Symptoms Without Side Effects: Mouse Study (news & abst–2016) http://neurosciencenews.com/schizophrenia-compound-striatum-5089/
Treating Depression in Alcoholics (news & abst–2016) http://neurosciencenews.com/alcoholism-depression-psychology-3541/
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of
adolescent rats (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0304394016302907
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of
rats treated with cocaine during adolescence (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/26797579
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid
signaling-related proteins in the mouse hippocampus (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26811312
Interplay between serotonin and cannabinoid function in the amygdala in fear
conditioning (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820636
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26833913
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1043661816000396
Immunohistochemical distribution of the cannabinoid receptor 1 and fatty acid amide
hydrolase in the dog claustrum (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0891061815300405
Functional effects of cannabinoids during dopaminergic specification of human neural
precursors derived from induced pluripotent stem cells (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27027565
Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1
cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1043661816303449
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Interaction between paired-pulse facilitation and long-term potentiation during the stimulation of the cannabinoid and vanilloid systems in the dentate gyrus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27130895
Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S016643281630256X
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273%2816%2930025-3
Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415301494
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice (abst–2016)  https://link.springer.com/article/10.1007%2Fs00429-016-1214-0
Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27208730
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27223629
Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816303187
Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca2+ spiking and multi-electrode arrays (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262380
Experimental Evidence that 3-Methylglutaric Acid Disturbs Mitochondrial Function and Induced Oxidative Stress in Rat Brain Synaptosomes: New Converging Mechanisms (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27278758
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stressinduced amnesia in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27282634
Ethanol downregulates N-acyl phosphatidylethanolamine-phospholipase D expression in BV2 microglial cells via epigenetic mechanisms (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27266665
Basolateral amygdala CB1 cannabinoid receptors are involved in cross state-dependent memory retrieval between morphine and ethanol (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716301083
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27345297
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models  (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304304
Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27441365
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor
URB597 may protect against cognitive impairment in rats of chronic cerebral
hypoperfusion via PI3K/AKT signaling (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0166432816304375
Endocannabinoids control vesicle release mode at midbrain periaqueductal grey
inhibitory synapses (abst–2016)  http://onlinelibrary.wiley.com/doi/10.1113/JP272292/abstract
Adolescent cannabis use: What is the evidence for functional brain alteration? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27514709
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus
in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27520083
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in
Astrocytes of Spontaneously Hypertensive Rats (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27529509
Anandamide reverses depressive-like behavior, neurochemical abnormalities and
oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27544303
mGluR1/5 activation in the lateral hypothalamus increases food intake via the
endocannabinoid system (abst–2016)
http://www.sciencedirect.com/science/article/pii/S0304394016305997
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and
infarct size during cerebral hypoperfusion and vascular dementia (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27586843
The neurobiology of social play and its rewarding value in rats (abst–2016)
http://www.sciencedirect.com/science/article/pii/S0149763416303724
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27578612
CB1 cannabinoid receptor-mediated anandamide signalling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27595886
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
Abnormal white matter integrity in synthetic cannabinoid users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27617779
Important role of endocannabinoid signaling in the development of functional vision and locomotion in zebrafish (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623930
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27634313
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303638
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016306930
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27649266
Cannabinoids: Glutamatergic Transmission and Kynurenines (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27651254
Expression of Dopamine Receptor 1A and Cannabinoid Receptor 1 Genes in the Cochlea and Brain after Salicylate-Induced Tinnitus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27658122
Interactive effects of AM251 and baclofen on synaptic plasticity in the rat dentate gyrus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27663967
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst–2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection (abst–2016) http://www.sciencedirect.com/science/article/pii/S016643281630715X
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686886
Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27698427
Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3 (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717809
Nature of the placebo and nocebo effect in relation to functional neurologic disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719874
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816304580
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816304579
Endocannabinoids and sleep (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416302640
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
Cannabinoid Receptor 2 Activation Restricts Fibrosis and Alleviates Hydrocephalus after Intraventricular Hemorrhage (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27769788
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27772772
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Differential Adulthood Onset mGlu5 Signaling Saves Prefrontal Function in the Fragile X Mouse (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797833
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Cannabinoid Modulation of Memory Consolidation within the Cerebellum (abst–2016) http://www.sciencedirect.com/science/article/pii/S1074742716302969
Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861247
Buzz Juice: Neurological sequelae of synthetic cannabinoids (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27865819
Neuromodulatory effects of the dorsal hippocampal endocannabinoid system in dextromethorphan/morphine-induced amnesia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916307282
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116303092
Fabp1 gene ablation inhibits high fat diet-induced increase in brain endocannabinoids. (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861894
Intra-VTA anandamide infusion produces dose-based biphasic effects on male rat sexual behavior expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302258
Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27889577
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302465
Cannabinoid modulation of zebrafish fear learning and its functional analysis investigated by c-Fos expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302854
Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system? (abst–2016) http://link.springer.com/article/10.1007%2Fs00441-016-2544-1
Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116300555
Chapter Eight – The Endocannabinoid System and Anxiety (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28061971
URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28042028
Signaling pathways to and from the hypophysial pars tuberalis, an important center for
the control of seasonal rhythms (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/28511899
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27964871
Enhanced immune response to MMP3 stimulation in microglia expressing mutant
huntingtin (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27033979
Impaired cued and spatial learning performance and altered cannabinoid CB1 receptor
functionality in the substantia nigra in a rat model of diabetic neuropathy (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300249
CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced
Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the
Nucleus Accumbens (abst–2016) http://link.springer.com/article/10.1007/s12031-016-0716-9
Physiological impact of CB1 receptor expression by hippocampal GABAergic
interneurons (abst–2016) https://link.springer.com/article/10.1007%2Fs00424-015-1782-5
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27261878
Physiological impact of CB1 receptor expression by hippocampal GABAergic  interneurons (abst–2016) https://link.springer.com/article/10.1007%2Fs00424-015-1782-5
Major dorsoventral differences in the modulation of the local CA1 hippocampal network
by NMDA, mGlu5, adenosine A2A and cannabinoid CB1 receptors (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/26762803
Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0028390816300545
Reversal effect of simvastatin on the decrease in cannabinoid receptor 1 density in 6-
hydroxydopamine lesioned rat brains (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27155397
Dorsal hippocampus cannabinoid type 1 receptors modulate the expression of contextual
fear conditioning in rats: Involvement of local glutamatergic/nitrergic and GABAergic
neurotransmissions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27591981
Effects of the antipsychotic paliperidone on stress-induced changes in the
endocannabinoid system in rat prefrontal cortex (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26987678
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1
mouse model of schizophrenia (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0278584616301269
Disruption of hippocampal synaptic transmission and long-term potentiation by
psychoactive synthetic cannabinoid ‘Spice’ compounds: comparison with Δ9 –
tetrahydrocannabinol (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26732435
Involvement of the orexin/hypocretin system in the pharmacological effects induced by
Δ9-tetrahydrocannabinol (abst–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940815/
Anatomical characterization of the cannabinoid cb1 receptor in cell type-specific mutant
mouse rescue models (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27339436
Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: a Dietary
Phytocannabinoid of Pharmaceutical Promise (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26965491
WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism (full–2017) https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0783-4 Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (full–2017) http://www.sciencedirect.com/science/article/pii/S221315821630170X
Synaptic Reorganization of the Perisomatic Inhibitory Network in Hippocampi of Temporal Lobe Epileptic Patients (full–2017) https://www.hindawi.com/journals/bmri/2017/7154295/
Changes in the Brain Endocannabinoid System in Rat Models of Depression (full-2017) http://link.springer.com/article/10.1007%2Fs12640-017-9708-y
Physicians disagree on legal age for cannabis (full–2017)  http://www.cmaj.ca/content/189/4/E174.long
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat
hypothalamus and hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28283967
Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in
the rat brain: involvement of CB1 and NMDA receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340665/
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure (full–2017) http://www.nature.com/articles/ncomms14782
Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of
Cannabinoid Receptor Subtype 1 (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00200/full
Endocannabinoid signaling in hypothalamic circuits regulates arousal from general
anesthesia in mice (full–2017) https://www.jci.org/articles/view/91038
Inhibiting parabrachial fatty acid amide hydrolase activity selectively increases the intake of palatable food via cannabinoid CB1 receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584854/
Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for
Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272923/
Addictive neurons (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479441/
Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation
Link between Inflammatory State and Neuro-Immune Alterations (full–2017)  http://www.mdpi.com/1422-0067/18/7/1425/htm
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and
peripheral nervous system (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181064
Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive
impairment in mice through anti-inflammatory activity (full–2017)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0913-7
Longitudinal study of hippocampal volumes in heavy cannabis users (full–2017) http://journals.sagepub.com/doi/10.1177/0269881117718380
Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder
Prevention (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535348/
Cognitive control in young adults with cannabis use disorder: An event-related brain
potential study (full–2017)  http://journals.sagepub.com/doi/full/10.1177/0269881117719262
The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial
orbital cortex of mice with acute stress (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553743/
Caffeine and Cannabis Effects on Vital Neurotransmitters and Enzymes in the Brain
Tissue of Juvenile Experimental Rats (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448447/
Ethanol Modulates the Spontaneous Complex Spike Waveform of Cerebellar Purkinje
Cells Recorded in vivo in Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328976/
Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are
Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189 (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562300/
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator
constitutively secreted by adrenals and in liver upon tissue damage (full–2017)  https://www.nature.com/articles/s41598-017-09808-8
Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of
Subventricular Zone and Dentate Gyrus Neurogenesis (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00516/full
Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression
Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid
Nanoparticles (full–2017) https://www.karger.com/Article/FullText/480001
Effects of arachidonyl-2′-chloroethylamide (ACEA) on the protective action of various
antiepileptic drugs in the 6-Hz corneal stimulation model in mice (full–2017)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183873
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of
Vascular Dementia (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
Anti-inflammatory ω-3 endocannabinoid epoxides (full–2017)  http://www.pnas.org/content/114/30/E6034.long
Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral
Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and
Memory Processing (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531370/
Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions
through conditional genetic rescue in forebrain GABAergic neurons (full–2017)  https://link.springer.com/article/10.1007%2Fs00429-017-1411-5
Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the
Endocannabinoid System in Brain Protection and Repair (full–2017)  https://link.springer.com/article/10.1007%2Fs11745-017-4292-8
Cannabinoid type 1 receptor-containing axons innervate NPY/AgRP neurons in the
mouse arcuate nucleus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369208/
The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal
Models (full–2017) http://www.mdpi.com/1422-0067/18/9/1916/htm
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges
and restores seizure-induced impairment of short and long-term synaptic plasticity (full–2017) https://www.nature.com/articles/s41598-017-11606-1
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum. (link to download-2017)  http://www.nature.com/npp/journal/vaop/naam/abs/npp201712a.html
Cannabinoids disrupt memory encoding by functionally isolating hippocampal CA1 from
CA3 (full–2017) http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005624
Residual Effects of THC via Novel Measures of Brain Perfusion and Metabolism in a
Large Group of Chronic Cannabis Users (full–2017)  http://www.nature.com/npp/journal/vaop/ncurrent/full/npp201744a.html
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in
the Rostral Ventromedial Medulla in Inflammatory Pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242409/
Involvement of the endocannabinoid system in the physiological response to transient
common carotid artery occlusion and reperfusion (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248520/
Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid Dependent Lipid Signaling (full–2017) http://www.cell.com/neuron/fulltext/S0896-6273(17)30109-5
Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and
central mechanisms (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407663/
Cannabis-induced alterations in brain activation during a test of information processing
speed in patients with MS (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433500/
Selectively Impaired Endocannabinoid-Dependent Long-Term Depression in the Lateral
Habenula in an Animal Model of Depression (full–2017)  http://www.sciencedirect.com/science/article/pii/S221112471730863X
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of
DA neurons in PD mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620217/
Blockade of Cannabinoid CB1 Receptors in the Dorsal Periaqueductal Gray Unmasks the
Antinociceptive Effect of Local Injections of Anandamide in Mice (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632997/
Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal
EEG in rats (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165363
A moderate diet restriction during pregnancy alters the levels of endocannabinoids and
endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of
rat offspring in a sex-specific manner (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174307
Molecular Imaging Markers to Track Huntington’s Disease Pathology (full–2017)  http://journal.frontiersin.org/article/10.3389/fneur.2017.00011/full
Inflammatory Regulation by Driving Microglial M2 Polarization: Neuroprotective
Effects of Cannabinoid Receptor-2 Activation in Intracerebral Hemorrhage (full–2017) http://journal.frontiersin.org/article/10.3389/fimmu.2017.00112/full
Δ9-Tetrahydrocannabinol Experience Influences ΔFosB and Downstream Gene
Expression in Prefrontal Cortex (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628572/
Reversal of age-related cognitive impairments in mice by an extremely low dose of
tetrahydrocannabinol (full–2017) http://www.neurobiologyofaging.org/article/S0197-4580(17)30321-4/fulltext
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to
cannabinoid-induced effects (full–2017)  http://www.sciencedirect.com/science/article/pii/S0024320517306069?via%3Dihub
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447368/
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
A cannabinoid receptor antagonist attenuates ghrelin-induced activation of the
mesolimbic dopamine system in mice (full–2017)  https://www.sciencedirect.com/science/article/pii/S0031938417304274?via%3Dihub
Cannabinoid Modulation of the Stressed Hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/
Dual Influence of Endocannabinoids on Long-Term Potentiation of Synaptic
Transmission (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742107/
Effects of chronic Δ9-tetrahydrocannabinol treatment on Rho/Rho-kinase signalization
pathway in mouse brain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681306/
Alterations in Rat Accumbens Endocannabinoid and GABA Content during Fentanyl
Treatment: The Role of Ghrelin (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713452/
Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol
Consumption in Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777574/
Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through
amygdala long-term depression in male rodents (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487270/
Interaction between urethane and cannabinoid CB1 receptor agonist and antagonist in
penicillin-induced epileptiform activity (click “Free Full PDF” for download–2017) https://www.ncbi.nlm.nih.gov/pubmed/28691717
Activation and Deactivation of 5-HT1 Receptor of Accumbens Shell Area does not Alter
ACPA-induced Aversive Memory Deficit in Male Rat (click “Free AIM full text” for download–2017) https://www.ncbi.nlm.nih.gov/pubmed/28287814
Simultaneous lipidomic and transcriptomic profiling in mouse brain punches of acute
epileptic seizure model compared to controls. (link to download–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29208697
CB1 Receptors Signaling in the Brain: Extracting Specificity from Ubiquity (link to PDF–2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp2017206a.html?foxtrotcallback=true
Brain cannabinoid receptor 2: expression, function and modulation (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/28065934
URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28092019
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104279
Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28106377
Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28109780
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138
Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28127623
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131675
Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28134998
Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28215162
Effects of tetrahydrocannabinol on glucose uptake in the rat brain (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817300564
FAAH Inhibition Produces Antidepressant-like efforts of Mice to Acute Stress via
Synaptic Long-term Depression (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28193523
Song-associated reward correlates with endocannabinoid-related gene expression in male European starlings (Sturnus vulgaris) (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0306452217300416
Endocannabinoid-dependent protection against kainic acid-induced long-term alteration
of brain oscillations in guinea pigs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28192082
A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix
Hemorrhage in the preterm via CX3CR1+ microglia (abst–2017)  http://www.sciencedirect.com/science/article/pii/S002839081730028X
Upregulation of fatty acid amide hydrolase in the dorsal periaqueductal gray is associated with neuropathic pain and reduced heart rate in rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28148494
URB597 reduces biochemical, behavioral and morphological alterations in two
neurotoxic models in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28157650
Lipid signaling and fat storage in the dark-eyed junco (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28161439
Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid
Amide Hydrolase Drive an Anxious Phenotype (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28209423
The effects of synthetic cannabinoids on executive function (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28160034
NMDA receptor adjusted co-administration of ecstasy and cannabinoid receptor-1
agonist in the amygdala via stimulation of BDNF/Trk-B/CREB pathway in adult male
rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28167133
Enhanced Ability of TRPV1 Channels in Regulating Glutamatergic Transmission after
Repeated Morphine Exposure in the Nucleus Accumbens of Rat (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28188777
Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor containing afferents in the noradrenergic nucleus locus coeruleus: implications for the
cognitive limb of the stress response (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28255675
Nutritional status dependent endocannabinoid signalling regulates the integration of rat
visceral information (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28233325
Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but
not sickness behaviour: An effect partially mediated by central TRPV1 (abst–2017)   ttps://www.ncbi.nlm.nih.gov/pubmed/28237711
Oleoylethanolamide: A fat ally in the fight against obesity (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28254531
Cannabis and alcohol use, and the developing brain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28223098
Repeated Acute Oral Exposure to Cannabis sativa Impaired Neurocognitive Behaviours
and Cortico-hippocampal Architectonics in Wistar Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28262852
HDAC1 and HDAC3 Underlie Dynamic H3K9 Acetylation During Embryonic Neurogenesis and in Schizophrenia-like Animals (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28300292
Cortical adrenoceptor expression, function and adaptation under conditions of
cannabinoid receptor deletion (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014488617300705
Presynaptic and extrasynaptic regulation of posterior nucleus of thalamus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28331010
Undercover Power of Endocannabinoids: Postsynaptic Ion-Channel Modulator (abst–2017) http://www.cell.com/neuron/abstract/S0896-6273(17)30197-6
Selective post-training time window for memory consolidation interference of
cannabidiol into the prefrontal cortex: reduced dopaminergic modulation and immediate gene expression in limbic circuits (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28344069
Cannabinoids as hippocampal network administrators (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301405?via%3Dihub
Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis (abst–2017) http://www.sciencedirect.com/science/article/pii/S0278584616302470
Anxious behavior induces elevated hippocampal Cb2 Receptor gene expression (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28392296
Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study (abst–2017)  http://link.springer.com/article/10.1007%2Fs00213-017-4601-1
Anandamide and 2-AG Are Endogenously Present within the Laterodorsal Tegmental
Nucleus: Functional Implications for a role of eCBs in arousal (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28404451
Marijuana on the Mind? The Impact of Marijuana on Cognition, Brain Structure, and
Brain Function, and Related Public Policy Implications (abst–2017)  http://journals.sagepub.com/doi/full/10.1177/2372732216684851
Lethal high: acute disseminated encephalomyelitis (ADEM) triggered by toxic effect of
synthetic cannabinoid black mamba (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28433979
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the
Modulation of Anxiety (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0006322317313574
2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate
receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28440729
CB1 receptors downregulate a cAMP/Epac2/PLC pathway to silence the nerve terminals
of cerebellar granule cells (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28445587
Endocannabinoid modulation of dopamine neurotransmission (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301831
Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via
changes in brain endocannabinoid system (abst–2017)  http://www.jlr.org/content/58/2/301.abstract
The rewarding effects of ethanol are modulated by binge eating of a high-fat diet during
adolescence (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301909
The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a
translational study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456476
A cannabinoid link between mitochondria and memory (abst–2017)  http://www.nature.com/nature/journal/v539/n7630/abs/nature20127.html
Fatty acid amide hydrolase (FAAH) regulates hypercapnia/ischemia-induced increases in
n-acylethanolamines in mouse brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28488728
Properties of the corticostriatal long term depression induced by medial prefrontal cortex high frequency stimulation in vivo (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301971
Cannabidiol in Medical Marijuana: Research Vistas and Potential Opportunities (abst–2017) http://www.sciencedirect.com/science/article/pii/S1043661817303559?via%3Dihub
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior (abst–2017) http://www.sciencedirect.com/science/article/pii/S0149763417300659
Atypical Endocannabinoid Signaling Initiates a New Form of Memory-Related Plasticity
at a Cortical Input to Hippocampus (abst–2017) https://academic.oup.com/cercor/article-abstract/doi/10.1093/cercor/bhx126/3829386/Atypical-Endocannabinoid-Signaling-Initiatesa-New?redirectedFrom=fulltext
Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced
Suppression of Excitation in the Anterior Cingulate Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28520841
Inhibition of SENP3 by URB597 ameliorates neurovascular unit dysfunction in rats with
chronic cerebral hypoperfusion (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28501776
N-stearoyl-l-Tyrosine inhibits the cell senescence and apoptosis induced by H2O2 in
HEK293/Tau cells via the CB2 receptor (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0009279716307293
Acetaminophen Metabolite N-Acylphenolamine Induces Analgesia via Transient
Receptor Potential Vanilloid 1 Receptors Expressed on the Primary Afferent Terminals
of C-fibers in the Spinal Dorsal Horn (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28542001
Nucleus Accumbens Functional Connectivity at Age 20 is Associated with Trajectory of
Adolescent Cannabis Use and Predicts Psychosocial Functioning in Young Adulthood  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28547854
Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via
endocannabinoid receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28554529
Sex- and hormone-dependent alterations in alcohol withdrawal-induced anxiety and
corticolimbic endocannabinoid signaling (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817302484
Recommendation to reconsider examining cannabis subtypes together due to opposing
effects on brain, cognition and behavior (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28579491
N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of
contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal
hippocampus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28583049
Long-Term Plasticity in Amygdala Circuits: Implication of CB1-Dependent LTD in
Stress (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28593436
Acylethanolamides and endocannabinoid signaling system in dorsal striatum of rats
exposed to perinatal asphyxia (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0304394017304743
2-Arachidonoylglycerol as a possible treatment for anorexia nervosa in animal model in
mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28606779
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic
stimuli: Possible involvement of the endocannabinoid and endovanilloid systems (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/19591935
Oral haloperidol or olanzapine intake produces distinct and region-specific increase in
cannabinoid receptor levels that is prevented by high fat diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28619471
Intra-accumbal blockade of endocannabinoid CB1 receptors impairs learning but not
retention of conditioned relief (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1074742717301016?via%3Dihub
Role of beta-catenin and endocannabinoids in the nucleus accumbens in extinction in rats exposed to shock and reminders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28624572
Synaptic functions of endocannabinoid signaling in health and disease (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817302861
The cannabinoid system and pain (abst–2017)  http://www.sciencedirect.com/science/article/pii/S002839081730285X
Hippocampal GR- and CB1-mediated mGluR5 differentially produces susceptibility and
resilience to acute and chronic mild stress in rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28629846
Remote memories are enhanced by COMT activity through dysregulation of the
endocannabinoid system in the prefrontal cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28630452
Chloramphenicol decreases CB1 receptor expression in the nucleus accumbens and
prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats (abst–2017) http://www.sciencedirect.com/science/article/pii/S0091305717301776
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28637354
Structural Neuroimaging Correlates of Alcohol and Cannabis Use in Adolescents and
Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28646566
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with
Dopamine and Endogenous Opioid Signaling (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28653666
Pregnenolone does not interfere with the effects of cannabinoids on synaptic transmission in the cerebellum and the nucleus accumbens (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1043661816301487
Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine induced dopamine release in the mouse nucleus accumbens (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28660730
A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic
plasticity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653801
Participation of hypothalamic CB1 receptors in reproductive axis disruption during
immune challenge (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28665507
Cannabinoids prevent the differential long-term effects of exposure to severe stress on
hippocampal- and amygdala-dependent memory and plasticity (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28667676
Cannabinoid reward and aversion effects in the posterior ventral tegmental area are
mediated through dissociable opiate receptor subtypes and separate amygdalar and
accumbal dopamine receptor substrates (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28669034
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain
Development (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28685756
CB₁ receptor antagonism in the bed nucleus of the stria terminalis interferes with
affective opioid withdrawal in rats (abst-2017)  https://www.ncbi.nlm.nih.gov/pubmed/28714716
Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine
densities in brain regions important to zebra finch vocal learning and production in an
antidepressant-sensitive manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28743448
Functional Analysis of Mitochondrial CB1 Cannabinoid Receptors (mtCB1) in the Brain  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28750801
Cannabinoid system of dorsomedial telencephalon modulates behavioral responses to
noxious stimulation in the fish Leporinus macrocephalus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28754268
Cannabidiol disrupts the consolidation of specific and generalized fear memories via
dorsal hippocampus CB1 and CB2 receptors (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303556?via%3Dihub
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28757328
Administrations of thalidomide into the rostral ventromedial medulla produce
antinociceptive effects in a rat model of postoperative pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28758232
N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of
contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal
hippocampus (abst–2017) http://journals.sagepub.com/doi/full/10.1177/0269881117691567
Regular cannabis and alcohol use is associated with resting-state time course power
spectra in incarcerated adolescents (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30324-1/fulltext
Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive
symptoms (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0278584617303676?via%3Dihub
The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation
in the amygdala and hippocampus on the consolidation of a traumatic event (abst–2017) http://www.sciencedirect.com/science/article/pii/S1074742717301284?via%3Dihub
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological
mechanisms, electroencephalographic profile, and brain cytokine levels (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(17)30322-0/abstract
Understanding marijuana’s effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot
investigation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28823723
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor
URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion
model by blocking NF-κB pathways (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28825114
17β-Estradiol Potentiates the Reinstatement of Cocaine Seeking in Female Rats: Role of
the Prelimbic Prefrontal Cortex and Cannabinoid Type-1 Receptors (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28825421
Chapter Eleven – Is the Cannabinoid CB2 Receptor a Major Regulator of the
Neuroinflammatory Axis of the Neurovascular Unit in Humans? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1054358917300376?via%3Dihub
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated
microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and
levodopa-induced dyskinesia (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28843453
2-arachidonoylglycerol metabolism is differently modulated by oligomeric and fibrillar
conformations of amyloid beta in synaptic terminals (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28844762
Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment
Induced by delta9-Tetrahydrocannabinol (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28816239
Inhibition of monoacylglycerol lipase: Another signalling pathway for potential
therapeutic targets in migraine? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28816506
Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following
Developmental Chlorpyrifos Exposure in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28820005
Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and
GDNF expression in a chronic MPTP mouse model of Parkinson’s disease (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0197018617301687
Increase in cortical endocannabinoid signaling in a rat model of basal forebrain
cholinergic dysfunction (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28827178
CHANGES IN THE CANNABINOIDS RECEPTORS IN RATS FOLLOWING TREATMENT WITH ANTIDEPRESSANTS (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0161813X17301717
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse
hippocampus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28888955
Changes in Gene Expression in the Locus Coeruleus-Amygdala Circuitry in Inhibitory Avoidance PTSD Model (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28889197
The Neurobiological Bases of Autism Spectrum Disorders The R451C-Neuroligin 3
mutation hampers the expression of long-term synaptic depression in the dorsal striatum (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28921757
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes,
hippocampal neuroglial reorganization and depression in mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28890155
Dose – specific effects of Di-isononyl phthalate on the endocannabinoid system and on
liver of female zebrafish (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28938452
Salvinorin A reduces neuropathic nociception in the insular cortex of the rat (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28975684
Involvement of cannabinoid system in the nucleus accumbens on delay-based decision
making in the rat (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28987618
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly
selective fatty acid amide hydrolase inhibitor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29017758
Adolescent cannabinoid exposure effects on natural reward seeking and learning in rats  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29022083
Cross state-dependency of learning between arachidonylcyclopropylamide (ACPA) and
muscimol in the mouse dorsal hippocampus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29032058
Neuronal nitric oxide synthase is involved in CB/TRPV1 signalling: Focus on control of
hippocampal hyperexcitability (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29035821
CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: a
Novel Target for Marijuana (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29038246
System-specific activity in response to Δ9 -tetrahydrocannabinol: A functional magnetic
resonance imaging study in awake male rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29057576
Linking Mitochondria and Synaptic Transmission: The CB1 Receptor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29058339
Differential tissue regulation of peroxisome proliferator-activated receptor α (PPARα)
and cannabinoid receptor 1 (CB1) gene transcription pathways by diethylene glycol
dibenzoate (DEGB): preliminary observations in a seabream (Sparus aurata) in vivo
model (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28843100
Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced
damage to hippocampal neurons: Dependence on the degree of injury (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28963903
Impact of dietary fats on brain functions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29046155
Metabolic effects of intermittent access to caloric or non-caloric sweetened solutions in
mice fed a high-caloric diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28347724
Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid
Mobilization in the Prelimbic Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29100630
Maternal high-fat diet induces sex-specific endocannabinoid system changes in newborn
rats and programs adiposity, energy expenditure and food preference in adulthood  (abst–2017) http://www.sciencedirect.com/science/article/pii/S0955286317303042?via%3Dihub
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and
cannabinoid systems in the rat brain (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817305142?via%3Dihub
Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats (abst–2017) http://www.sciencedirect.com/science/article/pii/S1734114017303663?via%3Dihub
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor
Expression in the Brains of Dams but Not Their Offspring (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29131068
Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic
hippocampal neurons (abst–2017)  http://www.sciencedirect.com/science/article/pii/S104366181730871X?via%3Dihub
LEARNING-INDUCED MODULATION OF THE EFFECT OF ENDOCANNABINOIDS ON INHIBITORY SYNAPTIC TRANSMISSION (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29167327
Acetaminophen Relieves Inflammatory Pain Through CB1 Cannabinoid Receptors in the
Rostral Ventromedial Medulla (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29167401
Adolescent ethanol intake alters cannabinoid type-1 receptor localization in astrocytes of
the adult mouse hippocampus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29168269
The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further
evidence for transporter-mediated endocannabinoid release (abst–2017)  https://www.sciencedirect.com/science/article/pii/S002839081730549X?via%3Dihub
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29171003
Examining Cholinergic Synaptic Signaling in the Thalamic Reticular Nucleus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28572192
Endocannabinoid-specific impairment in synaptic plasticity in striatum of Huntington’s  disease mouse model (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29192125
Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4766-7
Neuroprotective effects of drug-induced therapeutic hypothermia in central nervous
system diseases (abst–2017) http://www.eurekaselect.com/152965/article
Dorsal hippocampal cannabinergic and GABAergic systems modulate memory
consolidation in passive avoidance task (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0361923017305531?via%3Dihub
Activation of the cannabinoid system in the nucleus accumbens affects effort-based
decision making (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0091305717301387?via%3Dihub
Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in
normal and high-fat fed male C57BL/6J mice (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0041008X17304295?via%3Dihub
Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid
expression of innate anxiety and excessive alcohol intake (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29071769
Treating a novel plasticity defect rescues episodic memory in Fragile X model mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29133950
Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of
Dopamine Release in the Nucleus Accumbens (abst–2017)  http://www.cell.com/neuron/fulltext/S0896-6273(17)31065-6
Association between increased EEG signal complexity and cannabis dependence (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29132831
The Impact of Combinations of Alcohol, Nicotine, and Cannabis on Dynamic Brain
Connectivity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29134961
Visual attention to motion stimuli and its neural correlates in cannabis users (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29266467
Brain Volume Correlates with Duration of Abstinence from Substance Abuse in a Region-Specific and Substance-Specific Manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29308437
Effects of CB1 receptor antagonism and stress exposures in adolescence on
socioemotional behaviours, neuroendocrine stress responses, and expression of relevant
proteins in the hippocampus and prefrontal cortex in rats (full–2018)  https://www.sciencedirect.com/science/article/pii/S0028390817304963?via%3Dihub
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and
bipolar disorder patients with cannabis use (full–2018)  http://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)32024-2/fulltext
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity
and Improved Executive Function after 3 Months of Treatment (full–2018)
https://www.frontiersin.org/articles/10.3389/fphar.2017.00983/full
Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein
Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery
Occlusion and Reperfusion (full–2018) http://www.mdpi.com/1422-0067/19/2/426
Acute and chronic modulation of striatal endocannabinoid-mediated plasticity by
nicotine (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29292565
Role of the endogenous cannabinoid receptor 1 in brain injury induced by chronic
intermittent hypoxia in rats (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29264962
Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in
Olfactory Neuroepithelium Cells (abst–2018)  https://link.springer.com/article/10.1007%2Fs12035-017-0833-7
Thallium-Induced Toxicity in Rat Brain Crude Synaptosomal/Mitochondrial Fractions is
Sensitive to Anti-excitatory and Antioxidant Agents (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29313218
Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression
Alterations in the Basal Ganglia of Patients with Parkinson’s Disease (abst–2018)  https://link.springer.com/article/10.1007%2Fs13311-018-0603-x
Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington
mouse model and human ALS spinal cord tissue (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0223523417311285?via%3Dihub
Neural Regulation of Bone Remodeling: Identifying Novel Neural Molecules and
Pathways Between Brain and Bone (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29377116
Neuroimaging meta-analysis of cannabis use studies reveals convergent functional
alterations in brain regions supporting cognitive control and reward processing (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29338547
Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and
Related Comorbidities (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29372545
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration:
reversal by cannabidiol (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0361923017303714


BRAIN TRAUMA*+
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality (full-2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?toolubmed
N-arachidonoyl–serine is neuroprotective after traumatic brain injury by reducing apoptosis (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3170948/
Endocannabinoids and traumatic brain injury (full-2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3165950/?toolubmed
The dual neuroprotective-neurotoxic profile of cannabinoid drugs (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165949/
top
Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage (abst-2011) http/www.ncbi.nlm.nih.gov/pubmed/21315768
Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury (abst–2011) http/www.unboundmedicine.com/medline/ebm/record/21332427/abstract/Acute_effects_of_a_selective_cannabinoid_2_receptor_agonist_on_neuroinflammation_in_a_murine_model_of_traumatic_brain_injury_
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury (abst–2011) http://www.fasebj.org/content/25/1_Supplement/lb422.abstract?sid=ebd6611b-9cd5-451c-8d4c-a78d4d17cca1
Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections (full-2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3310878/?toolubmed
Cannabis Responsive Head Injury Induced Mutiple Disabilities: A Case Report (full-2012) http/file.scirp.org/Html/9-2500130_16958.htm
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full-2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268782/
Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/22696266
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/22903455
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)- tetrahydrocannabinol (THC): neuroprotection and ERK signaling (abst-2012) http/www.ncbi.nlm.nih.gov/pubmed/22821081
Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells (full-2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054271
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636589/
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier (full–2013) http/ajp.amjpathol.org/article/S0002-9440%2813%2900557-9/fulltext
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury (full-2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3734775/
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full-2013) http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00100/full#B12
Does the neuroprotective role of anandamide display diurnal variations? (link to PDF-2013) http/www.mdpi.com/1422-0067/14/12/23341
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (full–2013) http://www.biochemsoctrans.org/content/41/6/1577
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice (full–2013) http://cercor.oxfordjournals.org/content/25/1/35.long
Resuscitation from experimental traumatic brain injury by magnolol therapy (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23721932
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF-2013) http/www.eurekaselect.com/107976/article
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/22371074
top
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248435/
Endogenous Signaling by Omega-3 Docosahexaenoic Acid-derived Mediators Sustains Homeostatic Synaptic and Circuitry Integrity (full-2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3180614/
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24671870
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24819918
The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24937045
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/25058046
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348366/
Endocannabinoids in Synaptic Plasticity and Neuroprotection (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143501/
Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet (link to PDF-2014) http/www.ncbi.nlm.nih.gov/pubmed/24993629
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst-2014) http/www.ncbi.nlm.nih.gov/pubmed/24874648
Effect of marijuana use on outcomes in traumatic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25264643
Visual deficits in mice after mild traumatic brain injury produced by primary overpressure blast are alleviated by the novel CB2 drug SMM189 (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2271359&resultClick=1
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full-2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189 (full-2015) http://www.mdpi.com/1422-0067/16/1/758/htm
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways (full-2015) http://link.springer.com/article/10.1007/s11481-015-9609-x/fulltext.html
top
Cannabis – the Israeli perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0091/jbcpp-2015-0091.xml
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506688/
Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury (full–2015) http://jcb.sagepub.com/content/35/3/443.long
Correction to – Inhibition of Monoacylglycerol Lipase Prevents Chronic Traumatic Encephalopathy-Like Neuropathology in a Mouse Model of Repetitive Mild Closed Head Injury (full–2015) http://jcb.sagepub.com/content/35/4/706
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
Are the endocannabinoid-like compounds N-acyl aminoacids neuroprotective after traumatic brain injury? (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0092/jbcpp-2015-0092.xml
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury (full-2015) http://tinyurl.com/p8xwgww
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies (abst-2015)
http://www.ncbi.nlm.nih.gov/pubmed/25917763
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst-2015)
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI (full–2016)  http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0257-8
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
Endocannabinoids in Cerebrovascular Regulation (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury (full–2016) http://www.sciencedirect.com/science/article/pii/S0014488616300619
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27189876
CB1 Receptor Antagonism Prevents Long-Term Hyperexcitability after Head Injury by of Dynorphin-KOR System and mGluR5 in Rat Hippocampus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262683
Type-2 cannabinoid receptors in neurodegeneration (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Examining the Relationship Between Traumatic Brain Injury and Substance Use Outcomes in the Canadian Population (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27484302
Endogenous cannabinoid system alterations and their role in epileptogenesis after brain injury in rat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27810514
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full
Endocannabinoids: A Promising Impact for Traumatic Brain Injury (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/
Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical
Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury (full–2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00095/full
Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are
Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189 (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562300/
Cannabis Use Has Negligible Effects Following Severe Traumatic Injury (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28272189
Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain
injury to optimize and facilitate clinical translation (abst–2017)  http://www.sciencedirect.com/science/article/pii/S014976341730088X
Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29079445


BREASTFEEDING/LACTATION/INFANT APPETITE*+
Effects of increasing amounts of hempseed cake in the diet of dairy cows on the production and composition of milk (full-2010) http://tinyurl.com/q7e8vz9
Maternal Dietary Fat Determines Metabolic Profile and the Magnitude of
Endocannabinoid Inhibition of the Stress Response in Neonatal Rat Offspring (full–2010) http://endo.endojournals.org/content/151/4/1685.full?sid=f9729cff-d221-42d4-81d8-8545db5df878
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?tool=pubmed
Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21330091
Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice (full-2012) http://www.dmsjournal.com/content/4/1/35
Cannabinoid modulation of mother-infant interaction: is it just about milk? (abst-2012) http://www.degruyter.com/abstract/j/revneuro.2012.23.issue-5-6/revneuro-2012-0074/revneuro-2012-0074.xml?rskey=wRYgJd&result=1&q=cannabinoid
top
Detection of the endocannabinoid metabolome in human plasma and breast milk (abst-2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/45.8?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Continuous central infusion of cannabinoid receptor agonist WIN 55,212-2 decreases maternal care in lactating rats: Consequences for fear conditioning in adulthood males (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24060654
The CB1 cannabinoid receptor mediates glucocorticoid-induced effects on behavioural and neuronal responses during lactation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23417606
Development and validation of a sensitive UPLC-ESI-MS/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24377270
The endocannabinoid anandamide during lactation increases body fat content and CB1 receptor levels in mice adipose tissue (full-2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491858/
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25173887
Sensitive Quantification of Cannabinoids in Milk by Alkaline Saponification–Solid Phase
Extraction Combined with Isotope Dilution UPLC–MS/MS (full–2016)  http://pubs.acs.org/doi/full/10.1021/acsomega.6b00253
Dietary conjugated linoleic acid supplementation alters the expression of genes involved in the endocannabinoid system in the bovine endometrium and increases plasma progesterone concentrations (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262886
Oxylipins, endocannabinoids, and related compounds in human milk: levels and effects
of storage conditions (abst- 2016)  http://www.sciencedirect.com/science/article/pii/S1098882315300174
Oral Administration of the Endocannabinoid Anandamide during Lactation: Effects on
Hypothalamic Cannabinoid Type 1 Receptor and Food Intake in Adult Mice (full–2017) https://www.hindawi.com/journals/jnme/2017/2945010/
Pharmacologic Implications of Marijuana Use During Pregnancy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28599743
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor
Expression in the Brains of Dams but Not Their Offspring (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29131068


BULIMIA +
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19768813
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
The genetics of eating disorders (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21243475
Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21718968
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of
activity-based anorexia (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096804/?tool=pubmed
Dietary conditions and highly palatable food access alter rat cannabinoid receptor
expression and binding density (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621143/
Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22542985
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23829365
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
top

Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population (full-2014) http://onlinelibrary.wiley.com/doi/10.1002/mgg3.69/full
Endocannabinoids and Metabolic Disorders (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_10
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study (full–2016) http://www.nature.com/tp/journal/v6/n7/full/tp2016118a.html
Cannabinoid hyperemesis syndrome masquerading as an eating disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26842268
Peripheral Endocannabinoid Responses to Hedonic Eating in Binge-Eating Disorder (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748827/


BURNING MOUTH SYNDROME
Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis (full-2013) http://www.hh.um.es/pdf/Vol_29/29_4/Borsani-29-523-533-2014.pdf
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25150831


BURN INJURIES +
Image of the month. Skin discoloration from compulsive bathing in a patient with hyperemesis syndrome (full–2011) http://www.cghjournal.org/article/S1542-3565%2810%2900843-8/fulltext
Cannabinoid Receptor Type 1 Antagonist, AM251, Attenuates Mechanical Allodynia and Thermal Hyperalgesia after Burn Injury (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237656/
Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations  (warning–graphic photos) (full–2014)  http://www.healio.com/orthopedics/journals/ortho/2014-4-37-4/%7Be1c1de76-8467-4810-8e5f-8f18bde50169%7D/smokingsynthetic-marijuana-leads-to-self-mutilation-requiring-bilateral-amputations 
Butane Hash Oil Burns Associated with Marijuana Liberalization in Colorado (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675612/
Accelerated Burn Wound Closure in Mice with a New Formula Based on Traditional
Medicine (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292211/
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation
and Pain (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
Burns from illegal cannabis oil manufacturing: a case series (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29362215


BUSINESS OF CANNABIS/CANNABIS JOBS
Estimated Cost of Production for Legalized Cannabis (link to PDF–2010)  http://www.rand.org/pubs/working_papers/WR764.html
A Sociological Theory of Drug Sales, Gifts, and Frauds (full–2010) http://journals.sagepub.com/doi/full/10.1177/0011128710386199
The case for small-scale domestic cannabis cultivation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20176465
Colonic perforation: a lethal consequence of cannabis body packing (abst–2010)
http://www.ncbi.nlm.nih.gov/pubmed/20569954
What can we learn from the Dutch cannabis coffeeshop system? (abst–2011)
http://www.ncbi.nlm.nih.gov/pubmed/21906196
It can’t hurt to ask; a patient-centered quality of service assessment of health canada’s
medical cannabis policy and program (full–2012)https://harmreductionjournal.biomedcentral.com/articles/10.1186/1477-7517-9-2
Why small-scale cannabis growers stay small: Five mechanisms that prevent small-scale growers from going large scale (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23036648
Design considerations for legalizing cannabis: lessons inspired by analysis of California’s
Proposition 19 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21985069
Estimating the economic value of British Columbia’s domestic cannabis market:
implications for provincial cannabis policy (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/23085258
The economic geography of medical cannabis dispensaries in California (full–2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162636/
Establishing expertise: Canadian community-based medical cannabis dispensaries as
embodied health movement organisations (full–2013) http://www.ijdp.org/article/S0955-3959%2813%2900232-6/fulltext
“Body packers” in Israel: a case series (full–2013)  http://www.ima.org.il/FilesUpload/IMAJ/0/65/32679.pdf
Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24180513
From 32 ounces to zero: a medical geographic study of dispensing a cultivated batch of
“plum” cannabis flowers to medical marijuana patients in Washington State (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23909002
Big Marijuana — Lessons from Big Tobacco (link to download–2014)  http://www.mentalhealthportland.org/wp-content/uploads/2014/09/Big-Marijuana-%e2%80%94-Lessons-from-Big-Tobacco.pdf
Hashish as cash in a post-Soviet Kyrgyz village (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24594222
Are users’ most recent drug purchases representative? (full–2015)  http://www.drugandalcoholdependence.com/article/S0376-8716(14)00938-7/fulltext
“Should I Buy or Should I Grow?” How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655217
Issues in the implementation and evolution of the commercial recreational cannabis
market in Colorado (abst–2015) http://www.ijdp.org/article/S0955-3959(15)00354-0/abstract
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full
A Public Health Framework for Legalized Retail Marijuana Based on the US Experience: Avoiding a New Tobacco Industry (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038957/
Analysis of a commerical marijuana e-cigarette formulation (abst–2016) (This article has a delayed release and will be available in PMC on June 1, 2017) https://www.ncbi.nlm.nih.gov/pubmed/27059691
The commercial focus of US cannabis regulation models should not close our eyes to other options (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13383/full
Underbanked: Cooperative Banking as a Potential Solution to the Marijuana-Banking Problem (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27008718
top

Tightening the Dutch coffee shop policy: Evaluation of the private club and the residence criterion (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26944718
Estimating the production, consumption and export of cannabis: The Dutch case (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27048853
Field observations of the developing legal recreational cannabis economy in Washington State (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27296756
Why it is probably too soon to assess the public health effects of legalisation of  recreational cannabis use in the USA (abst–2016)  http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30071-2/abstract
Cannabis cultivation in Spain: A profile of plantations, growers and production systems  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27619556
Exploring Marijuana Advertising on Weedmaps, a Popular Online Directory (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27534665
High Time to Assess the Environmental Impacts of Cannabis Cultivation (full–2017) http://pubs.acs.org/doi/full/10.1021/acs.est.6b06343
Cannabis body packing: a case report (full–2017) http://www.panafrican-med-journal.com/content/article/24/327/full/#.WJ41gPJTLYY
Training and Practices of Cannabis Dispensary Staff (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531366/
Are dispensaries indispensable? Patient experiences of access to cannabis from medical
cannabis dispensaries in Canada (full–2017) http://www.ijdp.org/article/S0955-3959(17)30150-0/fulltext
Consumer use and understanding of labelling information on edible marijuana products
sold for recreational use in the states of Colorado and Washington (full–2017)
http://www.ijdp.org/article/S0955-3959(17)30008-7/fulltext
Patterns of Twitter Behavior Among Networks of Cannabis Dispensaries in California  (full–2017) http://www.jmir.org/2017/7/e236/
Expert Panel on Understanding Cannabis: Medicine, Society, Government (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657088/
Legalisation of non-medical cannabis in Canada: will supply regulations effectively serve
public health? (full–2017) http://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(17)30213-X/fulltext
Medical Decision-Making Processes and Online Behaviors Among Cannabis Dispensary
Staff (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570116/
Edible Marijuana Labeling and Packaging (1st page–2017)  http://journals.sagepub.com/doi/full/10.1177/0009922817691824
Uruguay’s middle-ground approach to cannabis legalization (1st page–2017)  http://www.ijdp.org/article/S0955-3959(17)30055-5/fulltext
Variation in cannabis potency and prices in a newly-legal market: Evidence from 30
million cannabis sales in Washington State (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28556310
Exposure to and Content of Marijuana Product Reviews (abst–2017)  https://link.springer.com/article/10.1007%2Fs11121-017-0818-9
Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing
relationship? (abst–2017) http://www.ijdp.org/article/S0955-3959(17)30292-X/fulltext
Into the void: Regulating pesticide use in Colorado’s commercial cannabis markets (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28173984
Regulating Cannabis Social Clubs: A comparative analysis of legal and self-regulatory
practices in Spain, Belgium and Uruguay (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189980
Community-level policy responses to state marijuana legalization in Washington State  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28365192
A practical framework for regulating for-profit recreational marijuana in US States:
Lessons from Colorado and Washington (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28366598
Exposure to Marijuana Marketing After Legalization of Retail Sales: Oregonians’
Experiences, 2015-2016 (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29161062
Consumer agency in cannabis supply – Exploring auto-regulatory documents of the
cannabis social clubs in Spain (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29367012
Microbial hazards during harvesting and processing at an outdoor United States cannabis farm (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29370578


Advertisements